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ABSTRACT

KAYLA RENEE HILL. The pathogenesis of noise-induced hearing loss is mediated by
the activation of AMPK via LKB1 and CaMKKβ. (Under the direction of SU-HUA SHA)

Noise-induced hearing loss (NIHL) is a major public health issue and an unresolved
clinical problem. Here we investigate pathomechanisms of auditory sensory cell death
and suggest a novel target pathway for intervention. Cellular survival from stress
depends upon maintenance of energy homeostasis, largely by the adenosine
monophosphate-activated protein kinase (AMPK) which coordinates metabolic pathways
with the energy demands of the cell. In response to traumatic noise exposure which
resulted in hair cell death, levels of p-AMPKα increased in hair cells in a noise intensitydependent manner. Inhibition of AMPK via administration of siRNA or a pharmacological
inhibitor attenuated noise-induced losses of hair cells and synaptic ribbons, and
preserved auditory sensitivity. The phosphorylation of liver kinase B1 (p-LKB1), an
AMPK kinase, was increased by noise exposure in cochlear tissues. Additionally, the
phosphorylation of calcium-calmodulin kinases I and IV (p-CaMKI/IV), the targets of
calcium-calmodulin kinase kinase beta (CaMKKβ), an alternative AMPK kinase that is
mediated by calcium, was increased in outer hair cells (OHCs) after the exposure.
Inhibition of LKB1 or CaMKKβ by siRNA or knockout mice reduced OHC loss and NIHL.
Finally, the increased p-AMPKα in OHCs after noise exposure was attenuated by
silencing LKB1 or using CaMKKβ knockout mice. These results indicate that noise
exposure leads to hair cell death by activating AMPK via LKB1- and CaMKKβ-mediated
pathways, facilitating the pathogenesis of NIHL.
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CHAPTER ONE: INTRODUCTION
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1. The structure and function of the ear
Hearing is our most sensitive organ and covers a great dynamic range. We are able to
hear a small sound from a pin dropping onto the floor to the piercing sound of a gunshot.
Hearing is also discriminative; we can distinguish the fine nuances during a concert.
Hearing is a complex process that involves the collection of sound wave vibrational
energy by the ear and the processing of these signals for interpretation by our brain. In
order to understand the changes of the mammalian auditory organ after exposure to
sound stimuli, I will take you on the journey through the three anatomical regions of the
ear: the outer ear, middle ear, and inner ear (Fig. 1).

Figure 1. The anatomical partitions of the ear. The ear consists of 3 main regions:
the outer, middle and inner ear. The outer ear consists of the pinna and external auditory
canal, which function to collect sound vibrations, which are then transferred to the middle
and inner ear. The middle ear begins at the tympanic membrane and consists of the 3
middle ear ossicles: the malleus, incus and stapes. The inner ear holds the cochlea and
the vestibular system, which are responsible for hearing function and balance,
respectively.
2

1.1 The outer and middle ear
The outer ear consists of two parts. The pinna, the only portion of the ear that is
externally visible, is primarily made of cartilage and skin and serves as a complicated
funnel to collect and enhance acoustic stimuli. Air-propagated sound waves are directed
into the external auditory canal, which conducts sound waves along its length to the
innermost limit of the canal, the tympanic membrane. The tympanic membrane, more
commonly known as the ear drum, is the boundary between the outer and middle ear. It
is a thin, cone-shaped membrane composed of radial fibers that have elastic properties,
which allow the structure to vibrate in response to acoustic waves. This transfers the
sound wave energy into vibrational energy, which is transferred to the middle ear via the
middle ear ossicles. The malleus, the first of the three ossicles, is attached to the medial
surface of the tympanic membrane and transfers acoustic vibrations to the incus, which,
in turn, connects to the stapes, forming a chain of ossicles for vibrational energy to pass
through towards the inner ear. The stapes sits on the oval window, an opening in the
bony wall of the cochlea that separates the middle ear from the inner ear. The fluid-filled
labyrinth of the cochlea is located on the medial side of the oval window. The impedance
mismatch between the air-filled middle ear and fluid-filled inner ear necessitates the
amplification of sound vibrations to effectively transfer the stimuli between the two
media. This amplification is achieved by concentrating vibrational energy from the
surface area of the tympanic membrane to the oval window, which is only 1/20 th of its
size, thus increasing the energy per area by 22 times.

3

1.2 The inner ear
The inner ear is composed of 2 functionally distinct organs: the vestibular system and
the cochlea. The vestibular system is responsible for balance and orientation in threedimensional space. The cochlea is dedicated to the detection of sound and will be the
focus of this dissertation. The cochlea is a bony, spiral shaped structure (Fig. 2). At its
core is the spongy bone of the modiolus from which the bony osseous spiral lamina
winds like a screw for 2.5 turns in humans. The cochlea is separated into three fluid-filled
cavities by the Reissner’s and basilar membrane: the scala vestibuli, scala media, and
scala tympani. The scala vestibuli and scala tympani make up the upper and lower
labyrinths and are filled with perilymph fluid which is composed of sodium (~145 mM),
chloride (~120 mM), bicarbonate (~20 mM), potassium (~5 mM) and calcium (~1 mM)
ions, comparable to cerebrospinal fluid.
The scala media, also known as the cochlear duct, is located in the middle of
these two canals. It is enclosed superiorly by the Reissner’s membrane, which forms a
barrier from the scala vestibule. Inferiorly, the scala media is enclosed by the basilar
membrane, which borders the scala tympani. The stria vascularis, the specialized
capillary-rich tissue which adheres to the spiral ligament, adjacent to the outer wall of the
bony cochlea and forms a lateral barrier. It is the specialized cells of stria vascularis that
are responsible for the potassium-rich characteristics of the endolymph fluid within the
scala media (1). The endolymph contrasts with perilymph composition primarily due to
its low sodium (~1 mM) and calcium (~0.02 mM), and high potassium (~160 mM)
concentrations. This specialized fluid maintains a high resting endocochlear potential
(EP) of 70-100 mV in comparison with the low 0-5 mV potential of the perilymph and the
-70 mV potential of hair cells. This potential difference between the endolymph and the
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hair cell is the largest electrical potential difference in the body and is essential to the
formation of an electrochemical gradient for the transduction current.

Figure 2. Cross-section of the cochlea. A cross section through the bony cochlea
reveals 3 fluid filled cavities: scala vestibuli (blue), scala media (red) and scala tympani
(green). The scala media is filled with endolymph and contains the organ of Corti, the
sensory organ of the inner ear. The scala tympani and scala vestibuli are filled with
perilymph. The Reissner’s membrane (RM) separates the scala media from the scala
vestibuli, while the basilar membrane (BM) provides a barrier for the scala tympani. The
spiral ganglion neurons of the cochlear nerve (yellow) are situated within the modiolus,
the central axis of the cochlea.
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The stapes sends vibrations through the oval window to the perilymph of the
scala vestibuli. The vibrational energy is transferred through the apical most point of the
cochlea where the perilymph of the scala vestibuli meets the scala tympani at the
helicotrema. The resulting pressure from the vibrations of the incompressible perilymph
fluid is released at the round window, where it pulses within the bony, inflexible structure
of the cochlea. The vibration of the fluids causes mechanical movement of the basilar
membrane. This vibratory pattern, also known as the traveling wave, depends upon the
characteristics of the basilar membrane, such as width and elasticity. As the basilar
membrane progresses apically from the base of the cochlea, its thickness increases and
alters its mechanical properties such as stiffness. Depending on the frequency of the
auditory stimulus, the site of maximal amplitude of the basilar membrane traveling wave
varies. Stimulation by high frequencies causes maximal amplitude of the traveling wave
toward the stapedial or basal end of the basilar membrane, which presents narrow and
stiff features. On the other hand, low-frequency stimuli causes maximal amplitude of the
traveling wave near the apical end, where the basilar membrane is more wide and
flaccid. These progressive changes create a tonotopic gradient that permits humans to
detect sound frequencies that range from 20 Hz – 20 kHz. On the other hand, the range
of mouse hearing, the model of focus in this study, extends from 2 – 90 kHz.
The organ of Corti rests on the basilar membrane within the scala media and
contains the sensory cells of the cochlea (Fig. 3). It is composed of one row of inner hair
cells (IHCs) located medially and three rows of outer hair cells (OHCs) located laterally.
In the human, there are 3,500 IHCs and 12,000 OHCs in the cochlea. The mouse
sensory epithelium contains 700 IHCs and 2,400 OHCs. The tunnel of Corti is formed by
the inner and outer pillar cells that separate the two sensory cell groups. Stereocilia
bundles are embedded at the cuticular plate, the uppermost region of hair cells. These
6

bundles are formed from three rows of stereocilia of graded length that are connected to
each other via tip links and lateral links. The stereociliary bundles of IHCs and OHCs
differ in their pattern; the former are in a lateral arrangement and the latter forms a “W”
pattern.

The OHC stereocilia bundles embed themselves firmly into the gelatinous

tectorial membrane, while IHC stereocilia are weakly connected.
The stereocilia at the top of the hair cell play a fundamental role in converting the
mechanical energy of the basilar membrane into electrical energy of hair cells for
conversion to neuronal signals. The key step in this process is the deflection of
stereocilia bundles, which causes the opening of mechanotransduction (MET) channels
at the tips of the stereocilia of hair cells. The displacement of the basilar membrane
forms shearing forces against the stereocilia bundles as they move up and down against
the tectorial membrane. The resulting bend of the stereocilia bundles increases the
tension of stereocilia tip links, which pulls the MET channels open (Fig. 4). A
depolarizing current of potassium and calcium ions from the endolymph (-70 mV) flows
through the MET channels and enters the hair cells (+80 mV). This depolarization opens
L-type voltage-gated calcium channels (VGCC) in the basolateral region of hair cells that
subsequently stimulate the influx of calcium proximal to the synaptic cleft, an active
region that contains synaptic ribbons surrounded by glutamate-filled synaptic vesicles.
These synaptic ribbons play a key role in the second half of this process by converting
the changes in hair cell membrane potential to chemical neuronal signals that are sent to
the brain. The secondary influx of calcium promotes the release of glutamate
neurotransmitter from synaptic vesicles into the synaptic cleft, which then activates αamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR) in afferent
nerve fibers that innervate the hair cells. The resulting action potential is carried by
afferent nerve fibers into the central nervous system.
7

Figure 3. The organ of Corti. The organ of Corti sits above the basilar membrane. The
stereocilia of the hair cells extend toward the tectorial membrane (pink). The IHCs
(green) form a single row on the modiolar side and are separated from the 3 rows of
OHCs (green) by 2 rows of pillar cells (purple) and the tunnel of Corti.

Figure 4. Deflection of stereocilia in mechanotransduction. The shearing force of
the tectorial membrane deflects the stereocilia (pink) of hair cells. This increases tension
in tip links (helix), which tugs the mechanotrasdution (MET) channels (yellow) open to
allow potassium and calcium ions (red) to enter.
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The displacement of the basilar membrane is further amplified by the
electromotility of OHCs, which allows them to change in length when stimulated. These
electromotile responses are driven by the voltage-dependent changes in OHCs following
the opening of mechanotransduction channels. The depolarization of OHCs changes the
conformation of voltage-sensitive prestin, an OHC specific motor protein. Prestin is
localized in the lateral plasma membranes of OHCs and alters its shape by binding
intracellular chloride. In a non-depolarized state, chloride ions allosterically bind to
prestin, resulting in an elongated shape. Upon basilar membrane displacement and
subsequent depolarization, chloride ions are dissociated from the prestin binding sites,
causing OHC contraction. The shape changes of prestin contracts and elongates the
length of OHCs, and serves to augment the amplitude of the traveling wave at a
particular frequency, and importantly, increases frequency sensitivity (2). This
mechanical feedback characteristic has led to the description of OHCs as the cochlear
amplifier to enhance mechanical stimulation of IHCs. Meanwhile, the IHCs are primarily
responsible for transducing electrical signals that are sent to the brain.
The contrasting functions of OHC and IHCs explain the variations in hair cell
innervation by the two subtypes of spiral ganglion neurons (SGN): Type I and Type II
SGNs. Type I SGNs make up the majority (95%) of SGNs. This subset is myelinated and
exclusively innervates IHCs. Each IHC is innervated by as many as 20 different afferents
from type I SGN which can be divided into three types in the murine model:

low

threshold-high spontaneous rate (SR), high threshold-low SR, and average thresholdaverage SR. The low threshold-high SR fibers are the most sensitive to noise exposure
and have small synaptic ribbons, but wide post-synaptic densities. The high thresholdlow SR fibers have large synaptic ribbons and small post-synaptic densities. In contrast,
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OHCs are only innervated by a single auditory afferent from Type II SGNs, each of
which innervate multiple OHCs and make up only 5% of auditory afferents.

2. Sensorineural hearing loss
According to the World Health Organization, 360 million people or 5.3% of the world
population have a disabling hearing loss and 15% are hearing impaired (3). Hearing loss
is divided into two main types: genetic hearing loss and acquired hearing loss. As the
name points out, genetic hearing loss is associated with inherited hearing loss. Acquired
hearing loss will be the focus of this dissertation. Acquired hearing loss describes the
loss of hearing function that develops during an individual’s lifetime as one is exposed to
various stresses, including viral or bacterial infections, aging, exposure to ototoxic drugs,
such as the chemotherapeutic cisplatin and aminoglycoside antibiotics, and exposure to
noise insults. The loss of hearing is mostly due to the fact that, unlike non-mammalian
vertebrates, mammalian cochlear sensory hair cells lack the ability to regenerate;
therefore, the loss or damage of mammalian hair cells in the cochlea is permanent and
results in a permanent sensorineural hearing loss.
Additionally, other inner ear disorders may also occur as a result of acquired
hearing loss. Tinnitus, commonly known as ringing in the ear, affects nearly 15% of the
world population and can severely affect quality of life. Meniere’s disease affects roughly
1-2% of the world population and causes spontaneous episodes of vertigo and hearing
loss. Among the numerous reasons of acquired hearing loss, noise exposure, the aging
process and treatment with ototoxic drugs are the three major causes. For my
dissertation, I will focus on the damage elicited on the cochlea by noise exposure.
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2.1 Noise-induced hearing loss
Exposure to loud sounds can cause damage to or death of cochlear hair cells, leading to
noise-induced hearing loss (NIHL). NIHL is one of the most common causes of acquired
hearing deficits and is one of the most frequent work-related disabilities in industrialized
countries (4). Worldwide, 250 million people suffer from NIHL (5). According to the
National Institute of Occupational Safety and Health (NIOSH), an estimated 30 million
workers are exposed to potentially hazardous noise from factories, construction sites,
and airports, in the U.S. alone (6). NIHL has become the most predominant disability in
war veterans, with an economic impact of $660 million in compensation payments
annually (7-9). Furthermore, exposure to recreational noise, such as listening to loud
music on personal listending devices, can also lead to NIHL (10).

2.2 Noise exposure
The magnitude of hearing loss depends upon the characteristics of noise, including the
intensity, duration, and temporal characteristics such as continuous noise or impulse
noise, a short-duration exposure to an intense sound (11). The greater the intensity
(perceived as loudness) of a sound stimulus, the greater the amount of damage can
occur to cochlear cells. Sound intensity is measured in decibels (dB), a logarithmic unit
of sound pressure level (SPL). Typically, normal moderate human conversation occurs
around 60 dB of intensity. Long or repeated exposures to sounds at 85 dB of intensity
and above (~300 times the energy level of 60 dB) can result in hearing a loss, thus
hearing protection is required by the Occupational Safety and Health Administration
(OSHA) for occupational exposures of 85 dB SPL. This intensity levels includes some
everyday sounds that many people may not consider harmful. The noises from a
lawnmower, for example, can get up to 90 dB of intensity. At 120 dB of intensity and
11

above instant hearing damage can occur. Noises such as chain saws and other power
tools have intensities of 110-120 dB. Around sixty million Americans own firearms,
exposing themselves to potentially 140-170 dB of noise without the proper use of ear
protectors.
Additionally, hearing loss can be induced with shorter exposure durations.
According to the NIOSH, exposure levels should be controlled in order to limit hazardous
levels of intensity and duration (12). To calculate the recommended exposure limit
(REL), the NIOSH generated a formula to combine the damaging effects of intensity
level (L) and duration (T):

T (min) = 480/2(L-85)/3(12). Using this formula, exposure

durations of no more than 8 h, a typical work day, is recommended for noise exposure
levels of 85 dB. On the other hand, shorter duration times of 15 minutes are endorsed
for exposure intensities of 100 dB.

2.3 Noise-induced cochlear pathology
NIHL can be divided into two subtypes: temporary hearing loss and permanent hearing
loss. The characteristic pathological feature of permanent hearing loss is the irreversible
loss of sensory hair cells, resulting in a loss of hearing function that does not recover. On
the other hand, lower levels of noise can cause a temporary hearing loss for minutes,
hours, or days, depending on the parameters of the stimulus (13).

2.4 Noise-induced temporary hearing loss
At the lower limit of damaging noise, reversible changes can occur, resulting in a
temporary auditory threshold shift (TTS), or temporary hearing loss that recovers within
a few days. In TTS, sensory hair cells, including both IHCs and OHCs, are not lost. The
pathological changes associated with TTS are not well understood.
12

Possible pathologies underlying TTS include swelling, fusion or distortion of
stereocilia, resulting in detachment of stereocilia from the tectorial membrane or a
reduction in the stiffness of stereocilia, both of which affect the deflection of stereocilia
and the subsequent mechanotransduction necessary for hair cell depolarization (14, 15).
Commonly, repairable excitotoxic effects are detected at the IHC synapses post TTS
noise exposure. The presence of swollen afferent fibers at the base of IHCs was
accompanied by vacuolization (16-18). More recently, studies have uncovered delayed
manifestations of neural degeneration of IHC synaptic ribbons and SGN loss regardless
of the reversibility of auditory threshold shifts and the absence sensory hair cell damage
(19-22). Despite the reversible effects of TTS, TTS noise exposure at a young age can
accelerate the synaptopathy of SGNs leading to age-related neuronal permanent
hearing loss (23). This observation has challenged the traditional view that degeneration
of SGNs occurs after sensory hair cell loss.

2.5 Noise-induced permanent hearing loss
Higher intensities of noise may result in a permanent auditory threshold shift (PTS), or
permanent hearing loss. This deficit in hearing function is believed to be a result of
metabolic and mechanical processes that damage the inner ear. Mechanical factors that
result from extremely high forces of acoustic stimuli cause excessive movement of the
cochlea, disrupting internal cellular structure, and typically inducing injuries rapidly after
exposure to the insult. On the other hand, metabolic damage is considered to be a more
gradual process that exhausts mitochondrial metabolism, alters homeostasis of cochlear
cells and fluids, increases oxidative stress and induces changes in energy production,
gene expression and protein synthesis. These changes can have various pathological
effects, including cell death, excitotoxicity, and structural damage.
13

PTS has several pathological correlates ranging from subtle defects to severe
lesions. Similar to the histopathology of TTS, stereocilia damage, including collapse,
breakage and fusion, can also occur under the PTS condition (24-27). Vacuolization in
the IHC is also common in the PTS condition (28). Furthermore, the innervating afferent
terminals of IHCs become swollen and degenerate, and at later times, are followed by
the degeneration of the afferent fibers and SGNs. Additionally, SGNs display a subset of
swollen satellite cells (28).
PTS is typically characterized by irreversible loss of sensory hair cells. OHCs are
more vulnerable than IHCs in the cochlea, but IHCs can also be damaged with
increased intensity of noise exposure (28). Noise-induced hair cell loss is a frequencyrelated damage in humans and in some animal models, such as guinea pig and
chinchilla; however, in mice and rats, hair cell susceptibility follows a base-to-apex
pattern as a result of noise-induced tonotopic damage, with basal hair cells being much
more easily damaged than the apically located cells. In contrast, supporting cell
structures

remain

generally

well-preserved,

although

reversible

or

permanent

pathologies may occur. After higher intensity noise exposures, and particularly impulse
noise, supporting cell structures can also be damaged by detachment from the basilar
membrane or by separation of cell-cell junctions due to mechanical movement of the
organ of Corti. This can change the impedance of the basilar membrane and affect the
sensitivity of hearing in that region. These structural disturbances can occur before
sensory hair cell death.
Severe exposures cause permanent degeneration of the fibrocytes of the spiral
limbus and spiral ligament, of which type II and IV fibrocytes are the most vulnerable
(28). Additionally, the stria vascularis might be acutely swollen, and may subsequently
shrink due to loss of intermediate and marginal cells. Vasoconstriction and capillary loss
14

in the spiral ligament as well as a decreased strial blood flow has also been detected
(29-31). These changes may transiently alter the EP, elevating auditory threshold shifts.
Noise insults caused by impulse noise, such as an explosion, can directly cause
mechanical damage to the inner ear (32). The extreme impact of vibrations can forcefully
cause the organ of Corti to detach from the basilar membrane, break the tympanic
membrane or damage the middle ear ossicles. Furthermore, the rupture of the basilar
and Reissner’s membranes may cause large ionic and osmotic changes that further
accelerate sensory hair cell death (33).

2.4 Noise-induced apoptosis and necrosis of hair cells
Noise-induced cochlear pathologies cause both apoptotic and necrotic hair cell death.
Apoptotic cell death is a programmed cell death pathway commonly characterized by
condensed nuclei with activation of multiple cell death pathways that are primarily
regulated by caspases. Caspase 8 and 9 are initiator caspases that are frequently
cleaved in extrinsic apoptotic pathways mediated by death receptors such as Fas cell
surface death receptor. Intrinsic apoptosis is primarily induced in response to
intracellular stress such as calcium overload or DNA damage. Intrinsic apoptosis is
associated with the formation of a pore on the outer mitochondrial membrane by the proapoptotic Bcl-2 family mediators, such as Bax. The activation of Bax causes uncoupling
of the mitochondrial membrane and mitochondrial membrane permeabilization, resulting
in the release of mitochondrial proteins and apoptotic factors, such as endonuclease G
and cytochrome C, into the cytosol (34).

Endonuclease G can translocate into the

nucleus where it is able to mediate DNA fragmentation. On the other hand, cytochrome
C initiates a cell death cascade that triggers the cleavage of caspase 9. Both of the
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extrinsic and intrinsic apoptotic pathways converge on caspase 3, the executioner
caspase, involved in the final stages of apoptosis (35).
The pathological feature of necrotic cell death is characterized by swollen nuclei
(36). The necrotic cell death pathways are not well understood, although recent studies
have proven that a regulated form, termed necroptosis, commonly occurs. In necrosis,
damage to the cell membrane causes a disruption of cell homeostasis as an influx of
fluid and extracellular ions enter the cell and eventually cause swelling and rupture.
Moreover, the membranes of internal organelles are also compromised, releasing
lysosomal enzymes that exacerbate the damage. In necroptosis, the receptor-interacting
protein (RIP) kinases 1 and 3 mediate necrotic cell death via the stimulation of death
receptors (37, 38). RIP1 can directly interact with the death domains of death receptors,
resulting in its activation and the subsequent cleavage of caspase 8. Additionally, RIP1
can also be activated through its interaction with RIP3.
Both apoptotic and necrotic cell death pathways have been detected in OHCs
following noise exposure (39-41). Caspases 8, 9 and 3 have been expressed in OHCs
with condensed nuclei after noise exposure (39, 42). Additionally, noise exposure
caused the release of cytochrome C and the translocation of endonuclease G, which
was detected in apoptotic OHCs (40, 41, 43, 44).
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Mode of Death

Morphology



Intrinsic
Apoptosis

Extrinsic
Apoptosis





Necroptosis



Cell shrinkage
Nuclear condensation
and fragmentation

Cell shrinkage
Nuclear condensation
and fragmentation
Cell swelling and
vacuolization
Nuclear swelling

Biochemical Features



2+







Intracellular stress (Ca , DNA damage)
Mitochondrial outer membrane
permeabilization (Bax, Bak)
Cytochrome C release
Nuclear translocation of EndoG and AIF
Activation of caspase-9, -3
Death receptor signaling
Activation of caspase-8, -3





Death receptor signaling
RIP1/3 activation
Activation of caspase-8

Table 1. Characteristics of cell death pathways. Apoptotic cells are primarily
characterized by nuclear condensation and induced by intracellular stress (intrinsic) or
death receptors (extrinsic), while necrotic nuclei are and may be initiated by membrane
permeabilization (necrosis) or death receptor signaling (necroptosis).

3. Mechanisms of noise-induced hearing loss
3.1 Evidence for noise-induced ATP reduction
Cochlear tissues use energy in the form of adenosine triphosphate (ATP) to maintain the
steep ionic gradients across cell membranes. Energy reserves, as determined by levels
of high energy phosphate, are primarily localized in the cells of the organ of Corti,
followed by the stria vascularis, and lowest levels within the SGN, although the rate of
energy metabolism is higher in the stria vascularis (45). Previous reports demonstrate
the noise-induced cellular reduction of ATP levels in the cochlea associated with noiseinduced permanent hearing loss, but no change with temporary hearing loss (40, 46-48).
In the cochlea, high intensity of noise exposure decreases capillary blood flow and
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caused local vasoconstriction (49, 50). The resulting ischemia decreases ATP levels
within the inner ear, including the lateral wall structures (46, 47, 51). The maintenance
of ATP levels via creatine, a compound that enhances cellular energy stores, attenuates
temporary and permanent NIHL in guinea pigs, suggesting that conservation of ATP
levels may prevent the initiation of subsequent pathological events such as free radical
formation (52). Creatine kinase is abundant in the stria vascularis marginal cells, it is
probable that the creatine treatment acts to maintain the endocochlear potential by
supplying ATP for ionic pumps since the endocochlear potential is reduced by noise
insults (53, 54).
Additionally, extracellular ATP can serve as a second messenger within the
cochlea. Extracellular ATP concentrations are increased in the endolymph fluid of the
guinea pig cochlea after noise insults, probably due to the release of ATP from vesicles
in the stria vascularis or gap junctional hemichannels of supporting cells (55-57). This
increase in extracellular ATP levels is implicated in both the pathogenesis and mitigation
of NIHL (58, 59). An exogenous delivery of ATP provides a protective response and
accelerates recovery from temporary threshold shifts in a guinea pig model possibly
through its effect in reducing the endocochlear potential to desensitize the sensory cell
response to noise insults (60). Extracellular ATP can initiate a variety of pathological
signaling pathways through the purinergic receptors in the inner ear including OHC
electromotility and calcium signaling, which may ultimately alter cochlear sensitivity (57,
61-63).

3.2 Evidence for noise-induced ROS production
The mitochondrial electron transport chain is implicated as a major source for reactive
oxygen species (ROS) produced by cochlear tissues. Due to the high energy demands
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of the cochlea, and particularly the stria vascularis in the maintenance of endolymph
ionic balance, ROS are often produced as a product of the mitochondrial metabolism.
During oxidative respiration, 98% of molecular oxygen is used by mitochondria to
generate ATP. Under normal physiological conditions, 1-2% of the molecular oxygen is
reduced to free radicals such as superoxide which can be oxidized to less toxic
hydrogen peroxide by mitochondrial superoxide dismutase (SOD). This level of ROS can
dramatically increase under pathological conditions (64, 65).
Increased ROS generation in cochlear tissues, including in OHCs, stria
vascularis, and fluids, by traumatic noise exposure is well documented and persists for
days after the exposure (66-71). Treatment with the superoxide generator paraquat
induces a similar pattern of OHC death and permanent auditory threshold shifts as that
induced by noise exposure, suggesting ROS as a cause for noise-induced cochlear
pathology (72). The most intriguing evidence for the role of oxidative stress in NIHL is
that treatment with a variety of antioxidants, such as Coenzyme Q, glutathione, Dmethionine, N-acetyl-cysteine, salicylate and trolox, reduces the extent of noise-induced
auditory deficits (71, 73-77). In line with this notion, basal OHCs, which are more
susceptible to noise damage, contain a lower level of the antioxidant glutathione
compared with their more resistant apical counterparts (78). Defects in antioxidant
genes, such as a single nucleotide polymorphism in the mitochondrial manganesesuperoxide dismutase gene in factor workers and glutathione peroxidase in mice
increased susceptibility to noise-induced hearing loss (79-81).
While the source for this elevated ROS is still unclear, theories speculate that
free radicals are triggered by the effects of ischemia-reperfusion or the influx of free
calcium on mitochondria via dysregulation of the calcium-regulated enzyme αketoglutarate dehydrogenase within the Krebs cycle (82). Furthermore, targeting the
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nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, the major
superoxide generator of the cell membrane, prior to noise exposure protects against hair
cell death and the elevation of auditory threshold shifts by lowering the level of ROS
generation (83). Supporting this concept, noise insults also induce the formation of the
ROS by-product and vasoconstrictor 8-isoprostaglandin F(2alpha) in cochlear tissues
and treatment with its antagonist block 8-isoprostaglandin F(2alpha)-induced reductions
in cochlear blood flow (CBF) (50). The ischemia-reperfusion that results from a decrease
in CBF may also contribute to increased oxidative stress.

3.3 Evidence for noise-induced calcium influx
Acoustic overstimulation has been shown to increase OHC cytoplasmic calcium
concentration in guinea pig sensory cells (84-86).

Evidence has demonstrated a

sustained 60% increase in calcium-dependent fluorescence in guinea pig OHCs
accompanied by a decrease in cochlear microphonics immediately following exposure to
extremely high levels of noise at 130 dB. On the other hand, normal sound levels of 75
and 88 dB did not alter intracellular calcium levels of cochlear sensory cells (85).
Moreover, in addition to increased fluorescence of free calcium in isolated OHCs of the
guinea pig cochlea, hearing loss and OHC death was also significantly increased
following high levels of noise exposure at 110 dB (85).
The role of calcium influx and signaling in the pathogenesis of NIHL is
emphasized by inner ear studies investigating the plasma membrane calcium-ATPase
(PMCA), the channel by which calcium is extruded to maintain the low intracellular
calcium concentration of hair cells and prevent calcium overload (87). Mutant PMCAnull mice displayed deafness while heterozygotes exhibited significant hearing loss (88).
Furthermore, the activation of calcium-dependent enzymes such as calcineurin increase
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in the dying OHCs of guinea pigs exposed to noise trauma. Treatment with inhibitors of
the calcium-dependent enzyme calcineurin, FK506 and cyclosporine A, reduce NIHL
and hair cell death (89).
In addition to increased intracellular OHC calcium concentration, endolymph
calcium levels increase by 50-fold in the noise-exposed guinea pig. This generates a
high ionic concentration gradient that results in the entry of calcium into sensory cells
through various channels, such as the VGCC and MET channels (90). At physiologic or
resting membrane potential, VGCCs are normally closed. These channels open when
excitable sensory cells are depolarized, allowing calcium entry into the cell. Several
VGCC subunits are in the auditory organ of the chinchilla, guinea pig, and murine
cochlea (91-93).

The α1 subunit of VGCC is the pore forming component that is

necessary for proper functioning of the channel.

In fact, its critical role in hearing

function is highlighted by evidence showing that α1D-deficient mice are deaf (94, 95).
Importantly, the VGCCα1 subunit is immunolocalized within IHCs and OHCs, but not
supporting cells, of the chinchilla cochlea (91). The basolateral localization of VGCCs
allow for the concentration of calcium influx at the synaptic ribbon active zone. The
calcium concentration at this nanodomain functions to trigger neurotransmitter release at
the ribbon synapse. However, an overloading of calcium influx can also cause
synaptopathy by stimulating the excessive release of glutamate neurotransmitters at the
synapse. The resulting overactivation of glutamate receptors on the post-synaptic
terminals can cause excitotoxicity and swelling of the nerve terminals, resulting

in

functional deficits.
VGCCs are composed of several channel types that vary in their physiological
roles. L-type and T-type VGCCs vary in their activation. L-type channels are high
voltage-activated channels that require stronger than ~30 mV depolarization to open.
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On the other hand, T-type channels are low voltage-activated channels that require only
small changes in the resting membrane potential (~10 mV) to open (93, 96). L-type
VGCCs are the predominant VGCC in IHCs and are also present in OHCs (97). Several
L-type channel blockers diltiazem, verapamil, nicardipine, and nimodipine reduce the
auditory threshold shift and decrease hair cell loss in female ddY mice at 8 weeks of age
(98). Delivery of the L-type, high voltage-activated channel blocker diltiazem protects
guinea pig OHCs from acute noise exposure (99). Furthermore, diltiazem treatment
reduces the calcium content of guinea pig IHCs and OHCs under normal conditions
(100). T-type channel blockers ethosuximide and trimethadione, delivered via drinking
water, also protect against hearing loss and OHC death primarily in the basal turn of the
C57BL/6 cochlea after noise exposure at 110 dB (101). Trimethadione protects against
both TTS and PTS hearing loss and hair cell death, while ethosuximide significantly
prevents only PTS (101).

3.4 Interplay of calcium, ATP and ROS
The previous sections review the three major metabolic events associated with NIHL:
reduction of intracellular ATP levels, calcium influx and generation of ROS. However, a
comprehensive mechanism of how these noise-induced metabolic stressors ultimately
alter cell fate causing noise-induced cochlear pathologies is still unknown. It is likely that
these changes in cellular energy, calcium and oxidative balance are interrelated in both
normal and pathological cell function.
The relationship between these metabolic phenomena is particularly apparent in
the mitochondrion. Under physiological conditions, calcium serves a beneficial function
as a stimulus for ATP synthesis. Mitochondria serve as calcium sinks that rapidly uptake
calcium via mitochondrial calcium uniporter (MCU) channels, providing buffering
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capacity for cytosolic calcium overload. These channels are located within the inner
mitochondrial membrane and transport calcium ions into the mitochondrial matrix
through a process that is primarily driven by the negative charge of the mitochondrial
membrane potential. This process is necessary for the stimulation of calcium-activated
dehydrogenases located in the mitochondrial matrix:

pyruvate dehydrogenase, α-

ketoglutarate and isocitrate dehydrogenase. The sum of these activities enhances the
aerobic respiration and the ATP output of the mitochondrion. The reduction of
mitochondrial membrane potential in mitochondrial disease reduces the uptake of
calcium into mitochondria and subsequent ATP production; treatment with a drug that
restores mitochondrial matrix calcium content restores ATP production (102).
Alternatively, increases in matrix calcium content can trigger a pathological
response. Calcium overloading of the mitochondrial matrix can reduce the mitochondrial
membrane potential and subsequently reduce ATP production. This may be caused by
a sustained opening of the mitochondrial permeability transition pore (mPTP) which is
associated with cell death pathways. In contrast, a lower mitochondrial calcium content
increases protective cellular functions such as autophagy, probably through increased
kinase activity of AMPK, rather than driving a pro-apoptotic response

(103). The

physiological calcium stimulus typically changes into a pathological response when the
cell is stressed due to accompanying insults which can include oxidative stress.
Calcium-mediated events can also directly affect ROS. For example, calcium can
stimulate electron flow from the Kreb cycle to increase aerobic respiration and its
associated ROS by-products. Additionally, calcium can stimulate the production of nitric
oxide via nitric oxide synthase in the cytosol which can subsequently act to inhibit
complex I or IV of the electron transport chain, enhancing ROS production (104). ROS
can regulate calcium levels and mitochondrial activity. ROS can activate mitochondrial
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uncoupling proteins to dissipate the mitochondrial membrane potential, which would
probably be accompanied by reduced ATP output, reduced uptake of mitochondrial
calcium and increased cytosolic calcium (105). On the other hand, ROS can also be
regulated by mitochondrial activity, since mitochondrial uncouplers decrease ROS
generation as well as ATP production (106, 107). This evidence highlights the
multifaceted interactions among these three metabolic events (108).
The relationship between these metabolic stressors is further complicated by the
often intertwining cross-talk and feedback loops that propagate the pathological
stimulus. For example, the calcium or ROS-induced release of cytochrome C from the
mPTP can disrupt the function of the inositol 1, 4, 5-triphosphate receptor (IP3R) on the
endoplasmic reticulum, another calcium store. A high cytosolic calcium level inhibits the
opening of this calcium to prevent ER calcium release under physiological conditions;
however,

the

cytochrome

C-induced

dysfunction

prevents

this

autoinhibition,

propagating the calcium overload (109). Extracellular ATP release by the marginal cells
of the stria vascularis can also regulate ER calcium release through the P2Y
metabotropic G-protein coupled receptors (GPCRs). The P2Y GPCRs activate
phospholipase C (PLC), an enzyme which cleaves membrane phospholipids, releasing
IP3. IP3 then binds to IP3R in the ER, activating calcium release into the cytosol.
Mitochondrial ROS also stimulate feedback loops that can cause mitochondrial
dysfunction. ROS generation within the matrix via complex I is sensitive to the
mitochondrial membrane potential and thus its dissipation can significantly reduce ROS
levels (110). Since uncoupling can be stimulated by ROS, a resulting feedback loop may
exist that further potentiates the dissipation of membrane potential. Meanwhile, it is likely
that this mitochondrial dysfunction will be accompanied by a reduced ATP output and
calcium uptake.
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Finally, since ATP is necessary for many ion pumps within the many cellular
membranes, any disruption of ATP levels will impact ionic balance across mitochondria,
cytosol and endoplasmic reticulum. The exacerbation of ion transport across
membranes will result in a disturbance in ion gradients that will worsen reduction in ATP
levels and aggravate ROS generation as a consequence. Thus, the initial stimulus of
intracellular calcium influx, ATP reduction or ROS generation can induce pathological
responses through sustained propagation of these cyclical actions. Moreover, the
complexities of these intertwining pathways challenge our understanding of the initiating
pathological stimuli and the subsequent turn of events.

4. Significance
The investigation of NIHL can have a profound impact on public health as noise trauma
is one of the most common causes of hearing loss in the adult population worldwide. In
addition to the detrimental auditory defects of noise on war veterans and industrial
workers, NIHL also poses negative economic consequences of $242.4 million annually
as NIHL has become one of the most common work-related disabilities (7). Since the
underlying molecular mechanisms of NIHL and the clinical therapy for its prevention and
treatment have not been established, detailed mechanisms of hair cell death in NIHL
need to be elucidated in order to identify new targets for the development of a
comprehensive therapy for translational research.
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CHAPTER TWO: MATERIALS AND METHODS
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Animals
Male CBA/J mice at the age of 11 weeks, breeding pairs of CaMKKβ C57BL/6J
heterozygous mice (B6.129X1-Camkk2tm1Tch/J; stock #014172), AMPKα1 C57BL/6
knockout mice (Prkaa1tm1.1Sjm/J; stock #014141) and wild type of C57BL/6J were
purchased from The Jackson Laboratory. All mice had free access to water and a
regular mouse diet (Purina 5025, St. Louis, MO) and were kept at 22 ± 1 °C under a
standard 12:12 hour light-dark cycle to acclimate for one week before the experiments.
All experiments were conducted at the age of 12 weeks for male CBA/J mice. A younger
age of seven weeks was used for CaMKKβ C57BL/6J knockout and littermates and
AMPKα1 C57BL/6J knockout and wild type mice due to the ahl homozygous mutation on
cadherin 23 which causes progressive age-related hearing loss in the C57BL/6J strain of
mice. All research protocols were approved by the Institutional Animal Care & Use
Committee at the Medical University of South Carolina (MUSC). Animal care was under
the supervision of the Division of Laboratory Animal Resources at MUSC.

Noise exposure
CBA/J mice at 12 weeks of age were exposed to a broadband noise (BBN) with a
frequency spectrum from 2–20 kHz for two hours at either 106 dB SPL to induce severe
permanent threshold shifts that range from 50 – 65 dB at high frequencies or 98 dB SPL
to induce moderate permanent threshold shifts (PTS) that range from 40 – 50 dB (71).
All knockout and wild type C57B/6J mice at seven weeks of age were exposed to three
different conditions of 94, 98 or 106 dB SPL BBN to induce PTS. Generally, four mice
(one mouse per stainless steel wire cage) were placed in a sound exposure chamber
and exposed at the same time. Age- and gender-matched control mice were kept within
the same chamber and cages for two hours without noise exposure. The sound
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exposure chamber was the same as we previously described (39, 40, 71). Briefly, it was
fitted with a loudspeaker (model 2450H; JBL) driven by a power amplifier (model XLS
202D; Crown Audio) fed from a CD player (model CD-200; Tascam TEAC American)
which played BBN. Audio CD sound files were created and equalized with audio editing
software (Audition 3; Adobe System, Inc.). Sound levels were calibrated with a sound
level meter (model 1200; Quest Technologies) at multiple locations within the chamber
to ensure uniformity of the sound field among the four cages, and were measured before
and after exposure to ensure stability.

Auditory brainstem responses (ABR)
Mice were anesthetized with an intra-peritoneal (IP) injection of xylazine (10 mg/kg) and
ketamine (100 mg/kg), and then placed in a sound-isolated and electrically shielded
booth (Acoustic Systems, Austin, TX). Body temperature was maintained near 37 °C
with a heating pad. Acoustic stimuli were delivered monaurally to a Beyer earphone
attached to a customized plastic speculum inserted into the ear canal. Sub-dermal
electrodes were inserted at the vertex of the skull, under the left ear and under the right
ear (ground). ABRs were measured at 8, 16, and 32 kHz. Tucker Davis Technology
(TDT) System III hardware and SigGen/Biosig software were used to present the stimuli
(15 ms duration tone bursts with 1 ms rise-fall time) and record the response. Up to 1200
responses were averaged for each stimulus level. Thresholds were determined for each
frequency by reducing the intensity in 10 dB increments and then in 5 dB steps near
threshold until no organized responses were detected. Thresholds were estimated
between the lowest stimulus level where a response was observed and the highest level
without response. All ABR measurements were conducted by the same experimenter.
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Drug administration via intra-peritoneal (IP) route
The pharmacological AMPK inhibitor compound C (Sigma #P5499) was dissolved in
dimethyl sulfoxide (DMSO) as a stock solution (31.25 mg/mL) and stored at -20 °C. The
stock solution was diluted in 0.9% saline immediately before being injected into animals.
Each animal received a total of three IP injections at a dose of 20 mg/kg or 10 mg/kg per
injection. The three IP injections were administered 24 hours before, two hours before,
and immediately after noise exposure. The animals were euthanized one hour after
noise exposure and temporal bones were removed to dissect the cochlea for
immunofluorescence assays. The mice used for experiments to observe the progression
of ABR thresholds received an additional IP injection 24 hours after noise exposure.
Verapamil was dissolved in 0.9% saline solution as a stock solution (0.01 g/mL)
and stored at -20 ºC. The stock solution was diluted in saline immediately before being
injected into animals. Each animal received a total of five IP injections of verapamil at a
dose of 10 mg/kg per injection. The five IP injections were administered 24 and 1 hour
before, immediately after, 24 and 36 hours after noise exposure. The ABR thresholds
were measured two weeks after noise exposure (Fig. 5).

29

Figure 5. Drug administration via intraperitoneal injection. The doses of Compound
C and verapamil are illustrated. Injections of each drug were delivered prior to and after
a 2 h noise exposure (pink square). The time course (hours) shown is relative to noise
exposure and begins with time 0 at the start of the 2 h noise exposure. Time points prior
to noise exposure are noted with a negative sign (-).
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Intra-tympanic delivery of siRNA
siAMPKα1 (Invitrogen #s98535), siLKB1 (Invitrogen #s74497), siCaMKKβ (Invitrogen
#n437808) or scrambled siRNA (siControl) (Invitrogen) was locally delivered via intratympanic application, which allows the entry of siRNA specifically within sensory hair
cells and minimal detection in other cochlear cell types (40, 111, 112). Briefly, after
anesthesia, a retroauricular incision was made to approach the temporal bone. The otic
bulla was identified ventral to the facial nerve and a shallow hole was made in the thin
part of the otic bulla with a 30 G needle and enlarged with a dental drill to a diameter of 2
mm to visualize the round window. A syringe was inserted into one end of a customized
sterile Micro Medical tube. The other end of the tube was inserted into the hole just
above the round window to slowly deliver 10 μL (0.3, 0.6 or 0.9 µg) of a single siRNA
species via syringe. After the siRNA delivery, the hole was covered with surrounding
muscle and glued with tissue adhesive. Lastly, the skin incision was closed with tissue
adhesive and the mouse was kept in the surgical position for one hour. Seventy-two
hours after siRNA delivery, the animals were exposed to noise or kept in silence in the
noise chamber for two hours.

Surface preparations and DAB staining of cochlear epithelia for hair cell counts
The procedures for surface preparations and diaminobenzidine (DAB) staining of
cochlear epithelia were followed as previously described (40). Briefly, the temporal
bones were removed immediately following euthanasia and perfused through the
cochlear scala media with a solution of 4% paraformaldehyde in phosphate buffered
saline, pH 7.4 (PBS) and kept in this fixative overnight at 4 °C. The cochleae were then
rinsed in PBS. The cochlea were decalcification in a 4% solution of sodium EDTA
(adjusted with HCl to pH 7.4) and the solution was changed daily for three days and
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maintained at 4 °C. Following decalcification, the cochleae were placed in 3% hydrogen
peroxide for 2.5 hours to quench endogenous peroxidases. After incubation in 10%
normal goat serum to block non-specific antibody binding overnight at 4 °C, the tissues
were incubated with a primary antibody (rabbit polyclonal anti-myosin VII, Proteus
Bioscience # 25-6790) at a 1:100 dilution for 4 days at 4 °C on a Nutator mixer, washed
in PBS, and then incubated overnight at 4 °C with secondary antibody (biotinylated goat
anti-rabbit) at a 1:100 dilution. The specimens were rinsed again and then incubated in
ABC solution (Vector Laboratories # PK-4001) overnight. Following another washing, the
cochleae were incubated in DAB for three hours, as necessary for sufficient staining
intensity, followed by washing to stop the DAB reaction. Finally, the cochleae were
micro-dissected under a microscope into apical, middle, and basal segments and
mounted on slides with Fluoromount-G mounting medium. Images were taken with Zeiss
AxioCam MRc5 camera with Axioplan 2 imaging software with a Zeiss microscope for
hair cell counts.

Hair cells were counted from captured images using the 40×

magnification lens on the Zeiss microscope. The lengths of the cochlear epithelia were
measured and recorded in millimeters. Both OHCs and IHCs were counted from the
apex to the base along the entire length of the mouse cochlear epithelium. Percentages
of hair cell loss in each 0.5 mm length of epithelium were plotted as a function of the
cochlear length as a cytocochleogram.

Immunohistochemistry for cochlear paraffin sections
Following decalcification with 4% EDTA, each cochlea was embedded in paraffin for
sections. The 5 μm formalin fixed paraffin embedded (FFPE) sections were routinely
deparaffinized in xylene and rehydrated in alcohol. The sections were incubated with
target retrieval solution (Dako S2367) in a steamer (Oster CKSTSTMD5-W) for 10
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minutes and then 3% hydrogen peroxide for 10 minutes and protein block (Dako x0909)
for 20 minutes at room temperature. Primary antibody was incubated overnight in a
humid chamber at 4 oC, followed by biotinylated secondary antibody (Vector, CA USA)
for 30 minutes and ABC reagent (Vector, CA USA) for 30 minutes. Immunocomplexes of
horseradish peroxidase were visualized by DAB (Dako, Glostrup, Denmark) reaction,
and sections were counterstained with hematoxylin before mounting.

Immunohistochemistry for cochlear surface preparations
Following decalcification with 4% EDTA, each cochlea for immunocytochemistry of
surface preparations was dissected under a microscope by removing the softened otic
capsule, stria vascularis, Reissner’s membrane, and tectorial membrane. The remaining
tissue, including the modiolus and cochlear sensory epithelium, was permeabilized in
3% Triton X-100 solution for 30 minutes at room temperature. The specimens were
washed three times with PBS and blocked with 10% goat serum for 30 minutes at room
temperature, followed by incubation in darkness at 4 °C for 72 hours with primary
antibodies: monoclonal rabbit anti-p-AMPKα (Thr 177) at 1:50 (Cell Signaling
Technology #2535S), monoclonal rabbit anti-AMPKα1 at 1:50 (Abcam #ab32047),
monoclonal rabbit anti-AMPKα2 at 1:100 (Abcam ab3760), monoclonal rabbit anti-LKB1
at 1:100 (Cell Signaling Technology #13031), monoclonal rabbit anti-p-LKB1 at 1:50
(Cell Signaling Technology #3482), monoclonal mouse anti-LYK5 (STRADα) at 1:100
(Sigma-Aldrich SAB1402648), monoclonal rabbit anti-CtBP2 at 1:100 (BD Biosciences
#612044), polyclonal rabbit anti-CaMKKβ at 1:100 (ThermoFisher #PA5-30399),
monoclonal rabbit anti-CaMKI at 1:100 (abcam #ab68234), and polyclonal rabbit antiCaMKIV at 1:100 (ProteinTech #13263-1-AP). After washing three times, the tissues
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were incubated with the Alexa Fluor 594 or 488-conjugated secondary antibody at a
concentration of 1:200 at 4 °C overnight in darkness. After washing, specimens were
incubated with Alexa Fluor 488 phalloidin at a concentration of 1:100 for 1 hour in
darkness. After the final wash with PBS, the tissue was dissected in PBS by removing
the modiolus. The epithelia were divided into three segments (apex, middle, and base).
Specimens were mounted on slides with Fluoro-gel with Tris buffer (Electron Microscopy
Sciences # 17985-10). Control incubations were processed without primary antibody
treatments. Images were taken using a Zeiss or Lecia laser confocal microscope (Zeiss
LSM 510 or Leica TCS SP5).

Quantification of the immunolabeled signals from outer hair cells of surface
preparations
Immunolabeled signals of OHCs on surface preparations was quantified from original
confocal images, each taken with a 63× magnification lens under identical conditions
and equal parameter settings for laser gains and PMT gains, using ImageJ software
(National Institutes of Health, Bethesda, MD). The cochleae from the different groups
were fixed and stained simultaneously with identical solutions and processed in parallel.
All of the surface preparations were counter-stained with Alexa Fluor 488 phalloidin
(green) to label hair cell structure. The borders of each individual OHC were outlined
with the circle tool based on the phalloidin staining. The immunofluorescence of the
target proteins were measured in the upper basal region of cochlear surface
preparations in 0.12 mm segments, each containing about 60 OHCs. The intensity of the
background fluorescence was subtracted and average fluorescence per cell was
calculated. The fluorescence was quantified by normalizing the ratio of average
fluorescence of noise-exposed hair cells to the average fluorescence of the unexposed
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hair cells. The overlap coefficient for LKB1 and STRADα in OHCs was determined using
Zeiss Zen colocalization software. In these studies, there were no differences in the
levels of p-AMPKα, LKB1, STRADα, p-CaMKI and p-CaMKIV molecules in OHCs of the
apical and middle turns between ears of control mice and those harvested one hour after
noise.

Quantification of the immunolabeled ribbons from Z projections on surface
preparations
Immunofluorescence of CtBP2 on surface preparations was quantified from original
confocal images, each taken with a 63× magnification lens under identical Z-stack
conditions with 0.25 intervals and equal parameter settings for laser gains and PMT
gains. Three Z-stack images each in 0.12 mm segments (containing about 16 IHCs)
were captured at the 22 kHz region (3 mm from the apex) of cochlear surface
preparations. The number of synaptic ribbons were counted using ImageJ software
(National Institutes of Health, Bethesda, MD). Briefly, the background of the images was
subtracted, the noise was despeckled and the threshold was set to isolate the
immunolabeling of ribbon signals from IHCs. The image was converted to a binary file
and the number of ribbon particles was counted using the 3D Object Counter. The binary
file was converted to a 3D zy projection to measure ribbon dispersion (Fig. 6).

Figure 6. 3D reconstruction of CtBP2-immunolabeled synaptic ribbons. (a) ImageJ
software was used to subtract background noise and isolate ribbon signals and convert
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to the 3D image. Dotted line: representative outline of IHC. Scale bar = 5 μm. (b) The
3D image was rotated along the x-axis to visualize a zy projection of the ribbons for
measurement of dispersion. Red line: representative line for measurement of dispersion
in zy projection.

Extraction of total cochlear protein
Cochleae were rapidly removed and dissected in ice-cold PBS, pH 7.4, containing
CompleteTM Mini EDTA-free protease inhibitor cocktail tablets (Roche Diagnostic GmbH
# 11836170001). To extract total protein, tissues from the cochleae of a single mouse
were homogenized in ice-cold RIPA lysis buffer containing RIPA lysis buffer (Sigma
Aldrich #R0278) plus Phosphatase Inhibitor Cocktails II and III, and Roche protease
inhibitor by using a glass/glass micro tissue grind pestle and vessel for 30 seconds.
Tissue debris were removed by centrifugation at 10,000 × g at 4 °C for 10 minutes and
the supernatants were retained as the total protein fractions. Protein concentrations
were determined using the Bio-Rad Protein Assay dye reagent (Bio-Rad) with bovine
serum albumin as a protein standard. Two cochleae from the same mouse were pooled
for each sample. Unless otherwise specified, all chemicals and reagents used were
purchased from Sigma Aldrich.

Extraction of protein from formalin-fixed sensory epithelium
Cochleae were rapidly removed and perfused with 4% paraformaldehyde through the
cochlea scala media for two hours at room temperature (25 °C). The cochleae were then
rinsed in PBS and decalcified in a 4% solution of sodium EDTA for three days at 4 °C,
with the EDTA solution changed daily. Following decalcification, the dissected sensory
epithelium from three cochleae were placed in 1.5 mL collection tubes with 100 μL of
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extraction buffer EXB plus (Qiagen Qproteome FFPE Tissue kit #37623) supplemented
with β-mercaptoethanol. Glass micro grinder pestles were used to grind the tissue for
three minutes. The tubes were sealed with a sealing clip and vortexed. The samples
were incubated on ice for five minutes, followed by vortexing. The tubes were then
incubated for 20 minutes at 100 °C on a heating block. After this incubation, the tubes
were incubated for two hours at 80 °C with agitation at 750 rpm (eppendorf) and then
allowed to cool at 4 °C for 1 minute. Finally, the samples were centrifuged at 14,000 x g
at 4 °C for 15 minutes. The supernatant containing the extracted proteins were
transferred to a new tube. Protein concentrations were determined using the Bio-Rad
RC DC protein assay (Invitrogen #500-0119) with bovine serum albumin as a protein
standard.

Western blot analysis
Protein samples (30 µg) were separated by SDS-PAGE. After electrophoresis, the
proteins were transferred onto a nitrocellulose membrane (Pierce Rockford, IL) which
was blocked with 5% nonfat dry milk in PBS-0.1% Tween 20 (PBS-T). The membranes
were incubated with anti-p-AMPKα (1:1,000), anti-AMPKα1 (1:1000), anti-p-LKB1
(1:1000), anti-LKB1 (1:1000), anti-CaMKKβ (1:1000), anti-CaMKI (1:1000), anti-CaMKIV
(1:1000) or anti-GAPDH (Millipore # ABS16, 1:10,000) at 4 °C overnight, and then
washed three times (10 minutes each) with PBS-T buffer. Membranes were incubated
with an appropriate secondary antibody at a concentration of 1:2,500 for one hour.
Following extensive washing of the membrane, the immunoreactive bands were
visualized by SuperSignal® West Dura Extended Duration Substrate or Pierce® ECL
Western Blotting Substrate (Thermo Scientific). X-ray films of Western blots were
scanned and analyzed using ImageJ software. The band densities were first normalized
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to background. Next, the probing protein/GAPDH ratio was calculated from the band
densities run on the same gel. Finally, the difference in the ratio of the control and
experimental bands was tested for statistical significance.

Extraction of total cochlear RNA for qPCR
Cochleae were rapidly removed and isolated in RNAlater (Invitrogen). Cochleae from a
single mouse were placed in a 2 mL tube with 100 μL of RNAlater and immediately
crushed with forceps. A 1 mL volume of TRIzol (Invitrogen) was added to each sample,
followed by homogenization with an RNase-free Polytron tissue grinder (Kinematica).
The samples were incubated for 5 minutes at room temperature prior to the addition of
0.2 mL of chloroform and vigorous shaking. After 2-3 minutes of incubation, the samples
were centrifuged at 12,000 × g at 4 °C for 15 minutes and the upper colorless aqueous
phase was retained and transferred to Phase Lock Gel Heavy (Eppendorf) tubes. The
0.2 mL of chloroform was added to each sample and followed by centrifugation at
12,000 × g at 4 °C for 10 minutes. The upper aqueous phase was transferred to a fresh
RNase-free tube for RNA precipitation with 1.5 μL of glycogen and 0.5 mL of
isopropanol, followed by centrifugation at 12,000 × g at 4 °C for 10 minutes. The RNA
pellet was washed in 75% ethanol and dissolved in DEPC water. RNA concentrations
were determined using the Nanodrop spectrophotometer. Absolute copy numbers were
analyzed using the QX100 Droplet Digital PCR System (Bio-Rad). Unless otherwise
specified, all chemicals and reagents used were purchased from Sigma Aldrich.

Statistical analysis
Data were analyzed using SYSTAT and GraphPad software for Windows. The group
size (n) in vivo was determined by the variability of measurements and the magnitude of
38

the differences between groups. Based on our previous and current preliminary studies,
we determined that six to eight animals per group provided sufficient statistical power (p
< 0.05). Statistical methods used include one-way Analysis of Variance (ANOVA) with
Tukey’s multiple comparisons, repeated-measures ANOVA with post-hoc testing,
unpaired t-tests, and one-sample t-tests. All tests were two-tailed and a p-value < 0.05
was considered statistically significant.
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CHAPTER THREE: AMPK ACTIVATION IN NOISE-INDUCED
HEARING LOSS

40

Introduction
The survival of essentially all organisms depends on the dynamic control of energy
metabolism during acute or prolonged exposure to various stress (113). Adenosine
monophosphate-activated protein kinase (AMPK) is a cellular energy sensor that is able
to detect and react to the fluctuations of the AMP:ATP ratio of the cell (114). This kinase
serves as a key regulator of energy homeostasis that coordinates metabolic pathways
with the energy demands of the cell by directing the cell to switch off energy consuming
activities and turn on energy-generating pathways (113, 115, 116). In response to an
increase in AMP levels, the AMPKγ subunit allosterically binds AMP, resulting in a 2-5
fold increase in the activity of AMPK (117). In addition to this allosteric activation, the
binding of AMP exposes the threonine 172 (T172) residue on the catalytic α-subunit to
reversible phosphorylation by upstream kinases such as liver kinase B1 (LKB1).
Moreover, the conformational change of the kinase domain induced by AMP binding
protects AMPK from the activity of phosphatases (118). This combined activation via
allosteric and phosphorylation mechanisms causes a 1000-fold increase in the kinase
activity of AMPK, allowing high sensitivity in response to small changes in the
intracellular energy status (119).
The regulation of cellular energy homeostasis by AMPK contributes to its role in
the determinations of cell fate as energy is necessary for cellular survival. Initially, the
activation of AMPK was considered an adaptive response to cellular stress; however,
there are diverse outcomes of AMPK activity on cell death and survival. In neuronal
cells, in particular, AMPK has a neuroprotective effect to glutamate excitotoxicity by
elevating Glucose Transporter 3 trafficking in response to a decrease in cellular ATP
levels (120). On the other hand, the sustained activation of AMPK has a hazardous
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effect on the cell in some models of cellular stress, including ischemia-reperfusion,
hypoxia and stroke (121, 122). The prolonged elevation of p-AMPK triggers the chronic
activation of the c-Jun N-terminal kinase (JNK), upregulation of pro-apoptotic Bim and
subsequent apoptosis in neuronal and pancreatic cells (120, 123, 124). AMPK is also
able to inhibit JNK activity in neuronal cells, suggesting that the regulation of cell fate by
AMPK is complex and may depend on the cell type and insult (120, 125, 126). Despite
the central functions of AMPK in the regulation of cell death and survival, no studies thus
far have elucidated the role of AMPK in noise-exposed sensory hair cells.
The small molecule Compound C (dorsomorphin) is a selective, potent, cellpermeable AMPK inhibitor through its ATP-competitive function (127). Many studies
demonstrate the effectiveness of Compound C in inhibiting the activation of AMPK and
its downstream activities. For example, treatment with Compound C in vivo protects
against stroke-induced cerebral damage. Validating its pharmacological target, this
neuroprotection is absent in AMPKα2-knockout mice (122).
Total AMPKα1 mRNA and protein expression is localized in murine cochlear
tissue, with predominant expression in OHCs (128). The phosphorylation of AMPKα is
detectable in OHCs and cochlear tissues, particularly after exposure to noise insults (40,
47). Furthermore, ROS-dependent robust activation of AMPKα is detected in the stria
vascularis in a transgenic mouse mitochondrial disease model that exhibits hearing loss
(129). In this chapter, our investigation focuses on the activation of AMPK by noise
exposure in the inner ear using the mouse model that our lab has characterized in detail.
We also explore the role of AMPK in the pathogenesis of NIHL using the
pharmacological inhibitor Compound C, siRNA silencing and knockout mice.
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Results
Noise conditions for temporary and permanent threshold shifts.
Based on our previously characterized parameters for CBA/ J mice, noise conditions for
TTS (92 dB SPL) without OHC loss, PTS (98 dB SPL) with only OHC loss, and severe
PTS (106 dB SPL) with both OHC and IHC loss were used (40, 71). Exposure of CBA/J
mice at 12 weeks of age to broadband noise (BBN, 2-20 kHz) for 2 h at 92 dB SPL did
not alter threshold shifts at 2 weeks after the exposure. On the other hand, a 98-dB
exposure increased threshold shifts by 30, 50, and 55 dB at 8, 16, and 32 kHz, and a
106-dB exposure resulted in even larger threshold shifts at all three measured
frequencies (Fig. 8a). Two weeks after noise exposure, the 98-dB exposure resulted in
partial OHC loss beginning around 3.5 mm from the apex and increasing toward the
base, while IHCs remained intact (Fig. 8c, d). The 106-dB noise exposure resulted in
loss of both OHCs and IHCs (Fig. 7). OHC loss began around 2.5 mm from the apex
(Fig. 8b) and IHC loss began around 4.5 mm from the apex (Fig. 8c), following a baseto-apex gradient with increased severity towards the base. The amount of OHC loss
induced by 106 dB SPL was significantly higher than by 98 dB SPL. Age-matched shamexposed control mice presented no elevation of auditory thresholds or hair cell loss 2
weeks after exposure. In agreement with the literature, synaptic ribbon number was also
reduced in an intensity-dependent fashion (19, 130). Two weeks after a 106-dB noise
exposure, the activity of auditory nerve fibers were decreased as determined by reduced
ABR wave I amplitudes at 8, 16 and 32 kHz (Fig. 9). Additionally, 1 h after a 98-dB noise
exposure, swelling of the spiral ganglion neuron bodies was apparent (Fig. 10).
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AMPKα is activated in basal outer hair cells by noise in an intensity-dependent
manner.
Using the above conditions, we first assessed the activation of the cellular metabolic
sensor AMPK after noise exposure at 92, 98 and 106 dB SPL in OHCs of surface
preparations. The expression of phosphorylated AMPKα (p-AMPKα) at threonine 172 in
OHCs 1 h after 92-dB exposure was similar to age-matched controls without the
exposure; however, immunolabeling for p-AMPKα in basal OHCs was increased by 60%
after 98-dB and 230% after 106-dB exposure compared to controls (Fig. 11a, a’). Since
changes in AMPKα phosphorylation were only detected under the PTS noise conditions,
PTS noise exposures were used for the rest of the study. To evaluate the localization of
this increased p-AMPKa in three key regions of the cochlea, the organ of Corti, spiral
ganglion and stria vascularis, p-AMPK was immunolabeled in cochlear sections. In the
control animal, immunolabeling for p-AMPKa in OHCs (arrow heads) and IHCs (arrow)
was weak. One hour after 98-dB noise exposure, the expression of p-AMPKα was
increased in IHCs and OHCs, but was only marginally increased and remained relatively
weak within the SGNs and the stria vascularis (Fig. 11c). Western blot using formalinfixed tissues of the sensory epithelium detected a single band for p-AMPKα at 63 kDa,
indicating the specificity of the antibody, although the band density was not altered with
noise exposure (Fig. 11b). Since noise increased the activation of AMPKα, we also
examined the expression of total AMPKα in cochlear cell types. In the control animal,
immunolabeling for AMPKα1 was primarily localized to supporting cells, such as Deiters’
and pillar cells of the organ of Corti. One hour after 98-dB noise exposure, the
immunolabeled AMPKα1 was increased in OHCs, IHCs and pillar cells in the organ of
Corti, SGNs, the stria vascularis, including marginal and basal cells, and fibrocytes in the
spiral ligament (Fig. 12a). Likewise, AMPKα2 immunolabeling was also increased in the
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nuclei and cytosol of IHCs, OHCs, supporting cells, SGNs, the stria vascularis, and
fibrocytes (Fig. 12b)

Inhibition of AMPKα1 by pretreatment with AMPKα1 siRNA or pharmacological
inhibitor compound C protected against noise-induced outer hair cell loss and
permanent hearing loss.
To determine the contribution of AMPKα to NIHL, AMPKα1 siRNA (siAMPKα1) was
used. First, three concentrations (0.3, 0.6 and 0.9 µg) of siAMPKa1 were tested in
preliminary in vivo experiments; 0.6 µg was selected for use in this study due to
efficiency of siRNA entry into hair cells. As described in Chapter 2, the intratympanic
delivery of siRNA resulted in the localization of siRNA specifically within OHCs and
minor detection in other cochlear cell types. Surface preparations revealed a 20%
reduction in AMPKα1 levels specifically within OHCs 72 h after treatment with 0.6 µg of
siAMPKα1, compared to OHCs of mice that received scrambled siRNA (siControl)
treatment. We then assessed if silencing AMPKα1 could diminish 98-dB noise-elevated
p-AMPKα in OHCs. Pretreatment with siAMPKα1 reduced 30% of noise-elevated pAMPKα in OHCs (Fig. 13a, a’). Furthermore, pretreatment with siAMPKα1 prevented
noise-induced OHC loss to baseline levels at 3 – 3.5 mm and significantly reduced OHC
loss by over 55% at 4 – 5.5 mm distances from the apex of the sensory epithelium two
weeks after the 98-dB exposure (Fig. 13d). Consequently, auditory threshold shifts of the
siAMPKα1-treated group recovered to near baseline levels at 8 kHz and were attenuated
from 50 to 10 dB at 16 and 32 kHz two weeks after 98-dB exposure (Fig. 13b). In
addition, the siAMPKα1 pretreatment significantly reduced auditory threshold shifts by 30
dB at 8 kHz and 20 dB at 16 and 32 kHz after exposure to 106-dB noise (Fig. 13c).
Since silencing AMPKα1 protected against noise-induced hair cell loss and NIHL,
next, the effects of compound C, a selective ATP-competitive inhibitor of AMPK were
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examined on noise-induced OHC death and hearing loss. Based on the literature, we
tested two concentrations (10 and 20 mg/kg) in adult CBA/J mice (131). Our preliminary
results indicated that mice receiving five doses of either concentration have normal
bodyweights and hearing thresholds. The fur of treated mice also appeared as shiny as
that of control mice and the mice displayed no overt signs of illness. Treatment with
either concentration of compound C significantly reduced the auditory threshold shifts at
8, 16 and 32 kHz two weeks after a 98-dB exposure in a dose-dependent fashion (Fig.
13e). Since the higher dose (20 mg/kg) of compound C elicited greater protection, OHC
loss was examined in animals treated with this concentration. OHC loss remained lower
than 10% throughout the basal region of the cochlea of compound C-treated mice two
weeks after 98-dB exposure, in contrast to 40%, 90% and 100% OHC loss which
occurred at 4, 5 and 5.5 mm from the apex in the vehicle (DMSO)-treated group (Fig.
13g). Furthermore, treatment with compound C also reduced OHC loss by 50-20% at 4 –
5.5 mm from the apex (Fig. 13h) and attenuated 106-dB noise-induced auditory
threshold shifts by 30, 15 and 20 dB at 8, 16 and 32 kHz 2 weeks after the exposure
(Fig. 13f). However, treatment with compound C did not alter 106-dB noise-induced IHC
loss (Fig. 13i).

Inhibition of AMPKα1 via AMPKα1 siRNA or Compound C prevented noiseinduced loss of inner hair cell synaptic ribbons and decline of wave I amplitudes.
In order to determine if blockade of AMPKa1 activation by siRNA or compound C can
attenuate noise-induced loss of IHC synaptic connections, ribbons were counted one
hour after, or ABR wave I amplitude was measured two weeks after noise exposure.
Exposure to 98-dB noise significantly reduced synaptic ribbon counts by 50% one hour
after the exposure, but the loss recovered to a level comparable to that of unexposed
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controls 14 days later (Fig. 15a). Due to the significant recovery at 14 days after
expsoures, the protection of synaptic ribbons was only examined after the 106 dB noise
exposure. The 106-dB noise exposure decreased CtBP2-labeled synaptic ribbons on
IHCs of surface preparations at 22 kHz (corresponding to a location 3 mm from the
apex) by 70% one hour after the exposure compared to unexposed controls.
Pretreatment with siAMPKα1 prevented loss of synaptic ribbons by 50% (Fig. 14a, b).
Additionally, noise exposure caused a wide dispersion of synaptic ribbons along the IHC
longitudinal axis, which was prevented with siAMPKα1 pretreatment (Fig. 14c). Although
106-dB noise exposure induced synaptic ribbon loss, this loss was also partially
recovered by 14 days after the exposure, but remained significantly lower than
unexposed controls (Fig. 15b). Pretreatment with siAMPKα1 still significantly protected
against the synaptic ribbon loss at 5, 8, 22 and 32 kHz, at a timepoint 14 days after the
exposure (Fig. 15c). ABR wave I amplitudes were examined 14 days after exposures at
8 kHz (1 mm from apex) and 16 kHz (2.4 mm from apex) in order to avoid regions of hair
cell loss (132). Fourteen days after exposure to 106 dB noise, the wave I amplitudes
were significantly decreased at sound intensities of 70 – 100 dB at 8 and 16 kHz,
compared to baseline controls. At 8 kHz, pretreatment with siAMPKα1 elevated the
amplitude at 100 dB by greater than 3-fold (Fig. 15d). The decline of wave I amplitudes
was also prevented at 16 kHz at 100 dB (Fig. 15e). Furthermore, treatment with
compound C reduced the noise-induced loss of synaptic ribbons per IHC by 50% one
hour after 106-dB noise exposure (Fig. 14d, e) and increased wave I amplitudes by 2fold at 8 kHz at intensities of 90 dB and 100 dB SPL compared to noise-exposed groups
at 14 days (Fig. 15f).
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Noise-induced hearing loss was exacerbated in AMPKα1-KO mice, but not outer
hair cell and synaptic ribbon loss.
To explore the pathological consequences of AMPK activation in NIHL, AMPKα1knockout (AMPKα1-KO) mice were used (128). The knockout of AMPKα1 resulted in an
80% reduction of p-AMPKα compared to WT littermates 1 hour after a 98-dB noise
exposure (Fig. 16e). Despite the knockout of the α1 isoform, AMPKa1-KO mice had
normal baseline auditory thresholds. Permanent threshold shifts were induced by 94, 98
and 106 dB SPL noise exposures as determined 2 weeks after the exposure. The 94-dB
noise exposure induced permanent threshold shifts of 30 dB at 16 and 32 kHz in both
AMPKα1-KO and –WT mice 14 days after the exposure (Fig. 16a). Exposures to noise
at both 98 and 106 dB SPL resulted in higher auditory threshold shifts for AMPKα1-KO
mice at 32 kHz compared to WT mice under the same conditions (Fig 16b, c). The 32
kHz threshold shifts of AMPKα1-KO mice were increased against AMPKα1-WT mice by
30 to 45 dB and 60 to 70 dB 14 days after 98 and 106 dB exposures, respectively.
Despite the threshold shifts, OHC loss was not altered in the cochlea of AMPKα1-KO
mice compared to WT mice 2 weeks after 98 dB exposure (Fig. 16d). Furthermore, the
number of synaptic ribbons at the middle turn (2.5 – 3.5 mm from the apex) did not differ
between AMPKα1-KO and –WT mice 1 h after a 106 dB exposure, even though the
noise exposure decreased CtBP2-labeled synaptic ribbons of WT mice by 50%
compared to unexposed WT controls (Fig. 17a, b).

48

Figure 7. Noise exposure caused a base-to-apex gradient of outer hair cell loss.
Representative images of DAB-stained myosin VIIa immunolabeled hair cells document
that OHC losses increase as a function of distance from the apex 14 days after noise
exposure at 106 dB SPL. Significant IHC losses also occurred in the base.
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Figure

8.

Noise

exposure

induced

permanent hearing loss and hair cell loss in
adult CBA/J mice. (a) 98 and 106 dB SPL
noise exposure induced significant auditory
threshold shifts at 8, 16, and 32 kHz as
detected 14 days after the exposures. n = 25.
(b) Quantification of OHC loss 14 days after
the exposures confirmed significant OHC loss
with 106 dB SPL versus 98 dB SPL. 98 dB: n
= 7; 106 dB:

n = 3. (c) 106 dB SPL noise

results in IHC losses in the basal turn. n = 5.
Data are presented as means + SD. */# p <
0.05, **/## p < 0.01, ***/### p <0.001.
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Figure 9. Noise exposure reduced the summed activity of auditory nerve fibers. (a,
b, c) 106 dB SPL noise reduced the wave I amplitude at 8 kHz (a) at sound intensities of
100, 90 and 90 dB SPL, at 16 kHz (b) at sound intensities of 90, 80, 70 and 60 dB SPL,
and at 32 kHz (c) at 100, 90, 80 and 70 dB SPL, 14 days after the exposure. Data (a, b,
c) are presented as means + SD, *** p < 0.001, * p < 0.05.
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Figure 10. Noise exposure caused swelling of spiral ganglion neurons. Sections of
the adult CBA/J mouse inner ear showed swelling of spiral ganglion neurons 1 h after 98
dB noise exposure. The swelling of noise-exposed spiral ganglion neurons is displayed
by the non-stained (white) regions. The nuclei of the SGNs are labeled blue by
hematoxylin and the cytosplasm can be viewed as pink by the eosin stain.
Representative images were taken from the basal turn, scale bar = 10 µm.
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Figure 11. Noise exposure increased p-AMPKα in basal outer and inner hair cells
intensity-dependent manner.
(a) The p-AMPKα (red) immunolabeling was stronger in basal OHCs with phalloidin
staining (green) 1 h after exposure to 98 and 106 dB noises than unexposed controls.
(a’) Immunolabeling of p-AMPKα in basal OHCs was significantly increased in a noise
intensity-dependent fashion. Control: n = 4; 98 dB: n = 3, 106 dB: n = 4. (b) Western blot
using sensory epithelium tissues displayed no difference in band densities of p-AMPKα
(60 kDa) 1 h after 98 and 106 dB exposures compared to controls. GAPDH served as
the loading control. n = 4. (c) Sections of the adult CBA/J mouse inner ear revealed
increased DAB-stained immunolabeling of p-AMPKα (brown) in IHCs (arrow) OHCs
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(arrowheads) of the organ of Corti, but no obvious changes were detected in spiral
ganglion neurons and stria vascularis 1 h after 98 dB noise exposure. Representative
images (a, c) were taken from the basal turn, scale bar = 10 µm. Data (a’, b) are
presented as means + SD, ** p < 0.01, * p < 0.05.
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Figure 12. Noise exposure increased total AMPKα1 and 2 in the organ of Corti. (a,
b) Sections of the normal adult CBA/J mouse inner ear revealed increase in DABstained immunolabeling of total AMPKα1 (a) or AMPKα2 (b) (brown) in the organ of
Corti, including in OHCs, IHCs, inner and outer pillar cells, spiral ganglion neurons,
marginal and basal cells of stria vascularis, and fibrocytes of spiral ligament 1 h after 98
dB noise exposure. AMPKα1 was mainly localized in cytosol, while AMPKα2 was
predominantly localized in the nuclei. Representative images were taken from the basal
turn, scale bar = 10 µm.
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Figure 13. Inhibition of AMPKα1 by siRNA and compound C protected against
noise-induced hearing loss and outer hair cell loss. (a) Treatment with siAMPKα1
decreased noise-induced immunolabeled AMPKα1 (red) in OHCs (labeled with
phalloidin staining in green) compared to siControl treatment 1 h after 98-dB exposure. .
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Representative images were taken from the basal turn, scale bar = 10 µm. (a’)
Quantification of AMPKα1 in OHCs confirmed a significant decrease. n = 3. (b, c)
siAMPKα1 pretreatment reduced 98 and 106 dB noise-induced permanent threshold
shifts. 98 dB: n = 18; 98 dB + siControl: n = 8; 98 dB + siAMPKα1: n = 7; 106 dB: n = 6;
106 dB + siControl: n = 3; 106 dB + siAMPKα1: n = 4. (d) Noise-induced (98 dB) OHC
loss was reduced by siAMPKα1 pretreatment. n = 3. (e) Compound C treatment reduced
98 dB noise-induced permanent threshold shifts in a dose-dependent fashion. 98 dB +
DMSO: n = 20; 98 dB + CC 10 mg/kg: n = 4; 98 dB + CC 20 mg/kg: n = 6. (f) Compound
C (20 mg/kg) treatment reduced 106 dB noise-induced permanent threshold shifts. n = 6.
(g) Compound C (20 mg/kg) treatment decreased 98 dB noise-induced OHC loss. 98 dB
+ DMSO: n = 7; 98 dB + CC 20 mg/kg: n = 6. (h) Compound C (20 mg/kg) treatment
decreased the extent of 106 dB noise-induced OHC loss. 106 dB + DMSO: n = 3; 106
dB + CC 20 mg/kg: n = 9. (i) Treament with compound C (20 mg/kg) did not alter 106 dB
noise-induced IHC losses. n = 4. (j) Representative image displays DAB-stained myosin
VIIa immunolabeling of sensory hair cells in the basal region of the control CBA/J
mouse. Data (a’, b, c, d, e, f, g, h, i) are presented as means + SD, 14 days after the
exposures, ***/### p < 0.001, **/## p < 0.01, */# p < 0.05.
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Figure 14. Inhibition of AMPK attenuated noise-induced inner hair cell synaptic
ribbon loss at 22 kHz one hour after 106-dB noise exposure. (a) Noise-induced loss
of immunolabeled CtBP2 (red) in IHCs was prevented by pretreatment with siAMPKα1.
(a’) Quantification of CtBP2 immunolabeled ribbon particles in IHCs confirmed that
noise-induced reduction of ribbons was partially prevented with siAMPKα1 pretreatment.
n = 4. (b) Noise-induced dispersion of CtBP2 immunolabeled ribbon particles along the
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IHC y-axis returned to baseline levels with siAMPKα1 pretreatment. n = 4. (c)
Compound C (20 mg/kg) treatment prevented the noise-induced loss of CtBP2 (red)
immunolableled synaptic ribbons in IHCs. (c’) Quantification of CtBP2 immunolabeled
ribbon particles in IHCs confirmed significant increases with compound C (20 mg/kg)
treatment. n = 4. Representative images (a, c) were taken from the 22 kHz region, n = 4,
scale bar = 10 µm. Dashed circles represent the outline of IHC nuclei. Data (a’, b, c’)
are presented as means + SD, *** p < 0.001, ** p < 0.01, * p < 0.05.
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Figure 15. Inhibition of AMPK protected noise-induced synaptopathy and noisedeclined auditory nerve activity 14 days after 106-dB exposure. (a) CtBP2
immunolabeled ribbon particles in IHCs at 22 kHz were significantly decreased 1 d after
98-dB noise exposure, but slowly recovered by 14 days after the exposure. n = 3. (b)
CtBP2 immunolabeled ribbon particles in IHCs at 22 kHz were significantly decreased 1
h after 106 dB noise exposure, but the loss partially recovered by 14 d after the
exposure. n = 10. (c) The noise-induced loss of CtBP2 immunolabeled ribbon particles in
IHCs were significantly reduced 14 days after 106 dB noise exposure. Pretreatment with
siAMPKα1 increased the number of synaptic ribbon particles at 5, 8, 22 and 32 kHz
regions of the sensory epithelium. Control: n = 4, 106 dB: n = 5, 106 dB + siControl: n =
5; 106 dB + siAMPKα1: n = 5. (d) Wave I amplitudes were reduced by 106 dB noise
exposure at sound intensities of 70 – 100 dB at 8 kHz. Pretreatment with siAMPKα1
elevated the wave I amplitude at sound intensities of 90 and 100 dB SPL. Control: n =
10; 106 dB + siControl: n = 8; 106 dB + siAMPKα1: n = 4. (e) The reduction of wave I
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amplitude by 106 dB noise was decreased by pretreatment with siAMPKα1 at sound
intensities of 90 and 100 dB SPL at 16 kHz. Control: n = 10; 106 dB + siControl: n = 6;
106 dB + siAMPKα1: n = 4. (f) The decrease of wave I amplitudes by 106 dB noise was
reduced by compound C (20 mg/kg) treatment at sound intensities of 90 and 100 dB
SPL at 8 kHz. Control: n = 10; 106 dB + DMSO: n = 14; 106 dB + CC 20 mg/kg: n = 4.
Data are presented as means + SD, *** p < 0.001, ** p < 0.01, * p < 0.05. For Data (c, d,
e, f), *: 106 dB + siControl vs 106 dB + siAMPKα1.
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Figure 16. AMPKα1-KO mice exacerbated noise-induced hearing loss. (a) The 94
dB SPL noise-induced permanent threshold shifts remained unchanged between
AMPKα1-KO and –WT mice 14 days after the exposure. n = 3. (b) The 98 dB SPL
noise-induced threshold shifts were increased at 32 kHz in AMPKα1-KO mice compared
to WT counterparts as determined 14 days after the exposure. n = 5. (c) The 106 dB
SPL noise-induced threshold shifts were increased at 32 kHz in AMPKα1-KO mice as
determined 14 days after the exposure. n = 8. (d) Noise-induced (98 dB) OHC loss was
not altered by AMPKα1-KO. n = 6. (e) The levels of p-AMPKα protein were reduced in
sensory epithelium tissues of AMPKα1-KO mice compared to WT counterparts exposed
to 98 dB SPL, but remained unchanged between unexposed AMPKα1-KO and –WT
mice. n = 4. Data are presented as means + SD, ** p <0.01, * p < 0.05.
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Figure 17. Noise-induced inner hair cell synaptic ribbon loss was not altered by
AMPKα1-KO. (a) The CtBP2-immunolabeled synaptic ribbons (red) in IHCs were
reduced by 50% at 22.6 kHz 1 h after exposure to noise at 106 dB compared to
unexposed cochlea. AMPKα1-KO did not alter the synaptic ribbon number compared to
WT mice under exposed or unexposed conditions. (b) CtBP2 immunolabeled ribbon
particles in IHCs were decreased 1 h after 106 dB noise exposure, but remained
unchanged by AMPKα1-KO mice. AMPKα1-WT: n = 3; 106 dB + AMPKα1-WT: n = 4;
106 dB + AMPKα1-KO: n = 4. Data are presented as means + SD, ** p <0.01, * p <
0.05.
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Discussion
Our results demonstrate for the first time that noise-induced phosphorylation of AMPKα
in sensory hair cells mediates NIHL by increasing losses of synaptic ribbons and OHCs.
Accordingly, agents that inhibit the activation of AMPK attenuated the loss of synaptic
ribbons and OHC, and subsequently NIHL. The noise-intensity dependent increase of pAMPKα1 is in line with our previous reports (39, 40) and provides support for the
concept of AMPK activation inducing hair cell death and NIHL. Additionally, total
AMPKα1 and AMPKα2 increase with noise exposure and are predominantly localized in
OHCs and IHCs as well as supporting cells such as Deiters and pillar cells, SGNs and
stria vascularis. Noise-induced increases in total AMPKα1 and α2 may provide sufficient
levels of kinase for phosphorylation; however, it is not clear if such an increase is due to
overexpression of the AMPKα gene or a decrease in protein degradation. An earlier
report detected expression of AMPKα1 mRNA only in OHCs, but not IHCs (128),
suggesting that noise-induced elevation of AMPKα1 in IHCs may not be related with
gene expression. AMPKα1 was primarily localized in the cytosol, while AMPKα2 was
localized in both the cytosol and nuclei. This isoform specific subcellular localization
implies potential alterations in function. Since AMPKα2 is found localized in the nuclei, it
is possible that this isoform is able to directly phosphorylate transcription factors and
alter gene expression, while the α1 isoform may have less of an impact on gene
expression and more of an effect in short term changes, such as the alteration of protein
activity.
Our evidence further supports the notion that AMPK activation leads to cell
death. Since similar functional protection was achieved by both pharmacological
inhibition and genetic silencing of AMPKα, we can conclude that treatment with siAMPK
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or Compound C provides protection against noise-induced stimuli through its inhibition of
AMPK.. It is surprising that pretreatment with siAMPKα1 reduces 98-dB thresholds shifts
by 80% at 16 and 32 kHz with only 20% reduction of AMPKα1 and 30% reduction of
noise elevated p-AMPKα levels detected in OHCs. This indicates that a specific partial
inhibition of AMPKα1 in OHCs is sufficient for prevention of noise-induced outer hair cell
loss and NIHL. Additionally, the activation of AMPK may alter multiple cellular targets
that result in an augmented effect (116). It is aslo logical that treatment with compound C
provides greater protection against noise-induced OHC losses compared to siAMPKα1
pretreatment, which only targets the α1 isoform. Still, Compound C and siAMPKα1
treatment does not reduce 106 dB noise-induced IHC losses, highlighting the severe
damaging effect of the noise intensity-dependent activation of AMPK and the potential
influence of multiple cell death pathways that may circumvent AMPK activation. For
example, we previously described the modulation of noise-induced OHC apoptosis and
necrosis by caspases and RIP-kinases, respectively. Inhibition of either pathway shifts
the prevalence of OHC death to the alternative pathway (39), supporting the concept
that multiple targets are necessary to comprehensively alter cell fate, especially for the
severe damage.
Our results are the first to implicate the activation of AMPK as a key initial
mediator affecting synaptic ribbons and functional deficits. Inhibition of AMPK either via
siAMPKα1 or Compound C reduces the extent of 106 dB noise-induced IHC synaptic
ribbon loss one hour and 14 days after exposures and protects against the decline of
wave I amplitudes associated with IHC synaptic density (19). The protection of synaptic
ribbons may contribute to the protection of auditory thresholds at 8 kHz without
corresponding loss of OHCs and IHCs (132, 133). Additionally, noise-induced synaptic
ribbon dispersion is in line with Liberman’s study (130). Our results demonstrate that
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such dispersion is also prevented by inhibition of AMPK by siRNA. This spatial disruption
may have significant functional implications since functional synapses require the
juxtaposition of pre-synaptic ribbons against post-synaptic terminals of auditory nerve
fibers. Although the post-synaptic terminals were not detected in this study, it is likely
that this synaptic ribbon dispersion is also associated with an increase in the number of
“orphan” ribbons and post-synaptic terminals that are non-functional. Additionally, both
98 and 106 dB exposures result in IHC synaptic ribbon loss that partially recovers over
time, suggesting that noise-induced synaptopathy is reversible at least to some extent
with the moderate noise damage. This contrasts with a previous report which showed no
significant recovery between 24 hours and 14 days post-exposure (130). This
discrepency may due to the variability of mouse stain. All of this evidence suggests that
AMPK may be a target for prevention of noise-induced synaptopathy.
Although pretreatment with siAMPKα1 or

the pharmacological inhibitor

compound C attenuates noise-induced losses of synaptic ribbons and OHCs and NIHL
in CBA/J mice, AMPKα1-KO C57B6/J mice exacerbated NIHL at both 98 and 106 dB
SPL, but not at noise conditions (90 - 94 dB SPL) that induces temporary or mild
threshold shifts (less than 30 dB). This is in line with previous reports showing
impairment of auditory threshold recovery after exposure to noise that causes temporary
threshold shifts in AMPKα1-KO mice compared to –WT mice (128). These differences in
lack of protection against NIHL in C57BL/6 and the excellent protection elicited by siRNA
and compound C are probably related to strain-dependent changes. The AMPKα1-KO
mice are on a C57BL/6 background and are thus not comparable to the CBA/J strain
used for the siRNA and compound C studies. The C57BL/6 strain is characterized by an
early onset age-related hearing loss that can develop as early as 1 – 6 months of age.
This phenotype is caused by the presence of a homozygous recessive ahl mutation of
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cadherin 23, which results in a splice variant that alters the stability and formation of
stereocilia tip links necessary for mechanotransduction. To avoid the accelerated agerelated hearing loss that is associated with this strain, the experiments with the C57BL/6
mice were conducted at a younger age of seven weeks, as opposed to three months of
age for CBA/J mice. This modified noise model results in threshold shifts of 35 and 30
dB at 16 and 32 kHz two weeks after a 98-dB noise exposure, contrasting with the 50 dB
threshold shifts induced in CBA/J mice at three months of age. Age-matched
comparisons of responses to noise exposures between the two strains were not made;
therefore, we cannot comment on the noise susceptibilities between the C57BL/6 versus
CBA/J mice with our noise conditions. However, other groups demonstrate that C57BL/6
mice are more susceptible to NIHL compared to age-matched CBA/J at older ages of
five to seven months due to the increased auditory degeneration associated with the
accelerated age-related hearing loss of the C57BL/6 strain (134). Still, it is clear that the
seven-week old C57BL/6 model used in this study induces a lower level of hearing loss
compared to the three-month old CBA/J model. This was also accompanied by lower
levels of hair cell losses.
The inconsistencies between the siRNA, compound C and knockout studies also
point to the intrinsic differences between the two methods of inhibition, in which siRNA
silencing transiently inhibits the expression of a gene, while a knockout eliminates gene
function for the animal’s entire lifespan. This fundamental difference is significant as it
can affect the outcome of the gene knockdown or knockout. For example, the outcome
of prolonged versus acute exposure to AMPK inhibition is different. A partial reduction of
AMPK, modeled by silencing and pharmacological inhibition, may prevent the noiseinduced imbalance of AMPKα1 signaling, whereas abolishment of cellular AMPK by
knockout of AMPKα1 alters other molecular events as well. Since AMPK is traditionally
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considered a protective enzyme that maintains cellular energy levels, we speculate that
noise insults initially trigger a protective response which may convert into a pathological
response with a hyper-elevated activation of AMPK. In line with this hypothesis, the
knockout of AMPKα1 would eliminate all functions, including initial protective responses
of AMPK, which may contribute to the deterioration of auditory sensitivity. The efficiency
of our protection strategies support this premise, with Compound C, a drug that targets
both AMPKα isoforms acutely, being the most effective, followed by AMPKα1 siRNA,
which targets the α1 isoform acutely and finally no protection elicited by the elimination
of the α1 isoform in AMPKα1-KO mice.
Despite the worsening of hearing function, the knockout of AMPKα1 does not
alter noise-induced losses of OHCs and synaptic ribbons. In fact, noise-induced OHC
loss is minimal at less than 10% loss, even at the very basal regions of the cochlea,
implying that sensory hair cell deficits may play a minor role in the pathology induced by
AMPKα1-KO mice and suggesting alteration of other molecular events, such as the
abundance of BK channels in OHCs, in exacerbating NIHL (128). Alternatively, we
speculate that the absence of protection by AMPKα1-KO mice may be caused by an
overcompensation of the other AMPKα2 isoform. Since compound C is not specific for a
particular AMPKα isoform, this overcompensation effect could be tested by
pharmacological treatment of AMPKα1-KO mice. If our hypothesis is true, treatment with
compound C should protect against NIHL in AMPKα1-KO mice due to its ability to
decrease AMPKα2 activity. Furthermore, the separate isoforms may also differ in
subcellular localization, targets and/or sensitivity to AMP, thus altering the response of
AMPKα1-KO mice to noise insults. Sections show AMPKα1 predominantly localized in
the cytosol of the cells of the cochlea, while the AMPKα2 isoform is found in both the
nucleus and cytoplasm. This difference in distribution implies potential alterations in
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function. Since AMPKα2 is found localized in the nuclei, it is possible that this isoform is
able to directly phosphorylate transcription factors and alter gene expression, while the
α1 isoform may have less of an impact on gene expression and more of an effect in
short term changes, such as the alteration of short term protein activity.
In agreement with the literature, AMPKα1 and 2 is also localized in the exposed
stria vascularis, mainly in the marginal cells and basal cells, where p-AMPKα has been
strongly detected post noise exposure in previous studies (47). The marginal cells of the
stria vascularis have high energy requirements due to the abundant expression of
sodium-potassium-ATPase (Na+-K+-ATPase) (135). To drive the active transport of ions
across the membranes, these cells contain a large number of mitochondria to generate
the necessary ATP (136). A transient cochlear ischemia inhibits the expression of Na+K+-ATPase and connexin 26, a marker for gap junctions through which K+ ions are
cycled, and subsequently reduces the endocochlear potential (137).
AMPKα1 and α2 are also strongly increased within the SGNs, which is
accompanied by swelling of the neuronal bodies. This is in line with reports in the
literature which demonstrate the swelling of afferent ribbon synapses, followed by
degeneration of SGNs at later times. Pathological cellular swelling is commonly
associated with an unregulated flux of cations, such as Na+, due to the failure of
extrusion mechanisms that require ATP. Along with this influx of cations, anions are also
driven into the cell, which subsequently drives the influx of water, causing the cell body
to swell. The primary extrusion mechanism to maintain a cation balance in neuronal cells
is Na+-K+-ATPase. Due to the energy-dependence of the extrusion pump, a depletion of
ATP in spiral ganglion neurons would reduce the active transport of cations out of the
cells and result in cellular swelling. Especially under noise-induced excitotoxic
conditions, high levels of glutamate released at the ribbon synapses activate N-methyl69

D-aspartate (NMDA) receptors which trigger the opening of non-selective cation
channels. The survival of the SGNs depends upon ATP to maintain the homeostatic
balance of the ATP-dependent extrusion pumps and the influx of non-selective cations
(138).
This evidence points to the stria vascularis, spiral ligament and spiral ganglion
neurons as potential sites for AMPK-mediated pathology that we have not yet
investigated since energy metabolism plays a critical role in the recycling of ions for the
endolymph as well as the ionic balance of SGNs after excitotoxic injury. Overall, the
results from this chapter point out a novel target for future development of drugs to
prevent or ameliorate NIHL and noise-induced cochlear synaptopathy.
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CHAPTER FOUR: AMPK ACTIVATION BY LKB1 VIA CELLULAR
ATP REDUCTION
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Introduction
Liver kinase B1 (LKB1) is an upstream serine/threonine kinase of AMPK which
phosphorylates the enzyme under low energy levels (139). LKB1 activity is regulated by
the adaptor protein Ste20 Related Adaptor (STRAD) and the scaffolding protein Mouse
Protein 25 (MO25), which exist in a 1:1:1 intracellular ratio (140).

STRAD is a

pseudokinase which allosterically binds the kinase domain of LKB1, while MO25
stabilizes the LKB1 activation loop by interacting with both LKB1 and STRAD. This
leaves the active site of LKB1 accessible, which is required for its kinase activity. The
formation of a stable heterotrimeric LKB1/STRAD/MO25 complex translocates LKB1
from the nuclei to the cytosol, where it exerts its serine/threonine kinase activity on
AMPK, when bound by AMP (141) (Fig. 18). A specific mechanism for the regulation of
the activation and inactivation of this heterotrimeric complex is yet unknown. The Cterminal region of LKB1 contains several post-translational phosphorylation sites,
including Serine 428 (S428). The phosphorylation of LKB1 at this site increased the
phosphorylation of AMPK, while its mutation abolished AMPK activation (142).
Moreover, the phosphorylation at S428 has been implicated as an important
nucleotranslocation signal, for LKB1 to be actively exported out of the nucleus (142,
143). In addition to AMPK, LKB1 directly phosphorylates a family of 14 various AMPKrelated kinases, such as the microtubule affinity regulating kinases (MARKs) (144).
Currently, no research in the field has examined LKB1 in the inner ear or its role
in NIHL or other inner ear disorders. In this chapter, the localization of LKB1 was
examined and its role in the pathogenesis or NIHL and the noise-induced activation of
AMPK was investigated.
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Figure 18. LKB1 activates AMPK. Inactive LKB1 is present in the nucleus and
becomes active when bound by its pseudokinase STRADα and adaptor protein MO25.
The stable, active LKB1-STRAD-MO25 complex can receive a phosphorylating
nucelotranslocation signal, which allows it be exported to the cytosol where LKB1
phosphorylates AMPK on threonine 172 of the α-subunit, in the presence of AMP
binding of the AMPKγ subunit, increasing the activity of AMPK by about 1000-fold.
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Results
Noise exposure increased the phosphorylation of LKB1 in the organ of Corti.
Since liver kinase B1 (LKB1) serves as the primary upstream kinase of AMPK, we
examined the phosphorylation of LKB1 (p-LKB1) levels in the cochlea in response to
noise insults. Immunoblots of total cochlear homogenates showed a single band for pLKB1 at the molecular weight of 54 kDa, which was robustly increased 1 h after the
exposure (Fig. 19c). No change was detected in total LKB1 levels (Fig. 19d). Increased
immunolabeling for p-LKB1 was localized to the nuclei and cytosol of the organ of Corti,
mainly in the OHCs, IHCs, Deiters and pillar cells 1 h following the exposure (Fig. 19a).
The increased immunolabeling for p-LKB1 in OHC cytosol was quantified on surface
preparations, which showed a greater than 2-fold increase in high-frequency OHCs 1 h
after the 98 dB exposure compared with controls (Fig. 19b).

No increases were

detected in low-frequency OHCs. Furthermore, the p-LKB1 was also increased in the
spiral ganglion neurons, the basal cells of the stria vascularis and the fibrocytes of the
spiral ligament after the exposure (Fig. 19a).

Noise exposure increased the colocalization of LKB1-STRADα in outer hair cells.
In addition to the phosphoration of LKB1 at serine 428, the activty of LKB1 can be
assessed by colocalization of LKB1 and STRADα in OHCs since LKB1 is allosterically
activated by binding to the psuedokinase STRADα. Immunolabeling for total LKB1 and
total STRADα in OHCs was increased by over 2-fold and almost 4-fold, respectively, 1 h
after 98-dB noise exposure compared to controls (Fig. 20a). The overlap coefficient for
LKB1-STRADα colocalization in OHCs was quantified and displayed a 2-fold increase in
1 h after noise exposure (Fig. 20b).
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Pretreatment with LKB1 siRNA reduced noise-induced p-LKB1 in outer hair cells,
noise-induced outer hair cells loss and auditory threshold shifts.
Since noise exposure resulted in activation of LKB1 in cochlear tissue, we evaluated the
role of LKB1 in NIHL using siRNA silencing techniques. First, pretreatment with 0.6 µg
siLKB1 resulted in a 20% reduction of total LKB1 specifically within OHCs and also
reduced the phosphorylation of LKB1 caused by 98-dB noise exposure by 25%,
compared to scrambled siRNA (siControl) treated groups (Fig. 21a). The siLKB1
pretreatment prevented the extent of noise-induced OHC loss to baseline levels at 3.5 –
4 mm and significantly reduced OHC loss by 50% at 4.5 – 5 mm from the apex (Fig.
21c). This correlated with the reduction of noise-induced auditory threshold shifts from
15 dB to baseline levels at 8 kHz and from 40-50 dB to 5 dB at both 16 and 32 kHz two
weeks after the exposure (Fig. 21b).

Pretreatment with LKB1 siRNA attenuated noise-induced losses of inner hair cell
synaptic ribbons and ABR wave I amplitudes.
To determine if inhibition of LKB1 activation by siRNA can attenuate noise-induced loss
of IHC synaptic ribbons, ribbon particles were counted 1 h after, or wave I amplitude was
measured 2 weeks after 106 dB noise exposure. For comparison with the protection of
synaptic ribbons by inhibition of AMPK, the 106 dB noise condition was used. Noise
exposure decreased CtBP2-labeled IHC synaptic ribbons from the 22 kHz region
(corresponding to 3 mm from the apex) by 70% compared to unexposed controls.
Pretreatment of siLKB1 prevented noise-induced synaptic ribbon loss. The ribbon count
increased from 5 to 8 ribbons per IHC (Fig. 21a, b). ABR wave I amplitudes were
examined at 8 (1 mm from apex) and 16 kHz (2.4 mm from apex) to avoid regions where
hair cell loss occurred (132). Pretreatment with siLKB1 recovered the noise-reduced
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ABR wave I amplitude at 70 and 80 dB at 8 kHz to baseline levels, and elevated the
wave I amplitudes by at least 3-fold at 16 kHz (Fig. 22c, d).

Silencing LKB1 reduced the noise-induced activation of AMPK in basal outer hair
cells.
To examine whether noise-induced phosphorylation of AMPKα1 is mediated by LKB1,
CBA/J mice were pretreated with siLKB1 72 h prior to noise exposure at 98 dB SPL.
Pretreatment with siLKB1 significantly reduced the 98 dB noise-induced immunolabeling
of p-AMPKα in basal OHCs by 20% (Fig. 23a, a’), indicating that LKB1 phosphorylates
AMPKα1.

76

Figure 19. Noise exposure increased p-LKB1 in the organ of Corti, spiral ganglion
neurons and spiral ligament. (a) Cochlear sections showed increased DAB-stained
immunolabeling of p-LKB1 (brown) in the cytosol and nuclei of OHCs, IHCs, supporting
cells, spiral ganglion neurons, basal cells of the stria vascularis and fibrocytes of the
spiral ligament 1 h after 98-dB noise exposure compared to unexposed controls.
Representative images were taken from the basal turn, scale bar = 10 µm, n = 5. (b)
Quantification of p-LKB1 immunolabeling in OHCs of surface preparations show
increases 1 h after the exposure. n = 4. (c) Western blot using total cochlear
homogenates showed increased p-LKB1 1 h after the exposure compared to controls.
GAPDH served as the sample loading control. n = 5. (d) The levels of total LKB1 were
not changed with noise exposure by Western analysis. n = 3. Data (b, c, d) are
presented as mean + SD, * p < 0.05, ** p < 0.01.
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Figure 20. Noise exposure increased LKB1-STRADα colocalization in outer hair
cells. (a) The LKB1 (red) and STRADα (blue) colocalization was stronger in OHCs
(green) 1 h after 98 dB SPL exposure. (b) Quantification of LKB1 and STRADα overlap
coefficient in OHCs displayed a significant increase after the noise exposure. n = 3. Data
(a, b) are presented as mean + SD, * p < 0.05.
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Figure 21. Inhibition of LKB1 reduced noise-induced p-LKB1 in outer hair cells,
loss of outer hair cell loss and ABR threshold shifts. (a) Pretreatment with siLKB1
significantly decreased p-LKB1 immunolabeling in OHCs 1 h after the exposure. n = 5.
(b) Pretreatment with siLKB1 reduced 98 dB noise-induced threshold shifts at 16 and 32
kHz 14 days after the exposure. n = 5. (c) Quantitative analysis of OHCs revealed
significant protection with siLKB1 pretreatment 14 d after the exposure. 98 dB +
siControl: n = 12; 98 dB + siLKB1: n = 3. Data (a, b, c) are presented as means + SD,
*** p < 0.001, ** p < 0.01, * p < 0.05.
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Figure 22. Inhibition of LKB1 partially prevented noise-induced inner hair cell
synaptic ribbon loss at 22 kHz and decline of ABR wave I amplitude. (a)
Pretreatment with siLKB1 increased the CtBP2 (red) immunolableled synaptic ribbons in
IHCs 1 h after 106-dB noise exposure. Representative images were taken from the
middle turn, n = 4, scale bar = 10 µm. Dashed circles show the outline of IHC nuclei. (b)
CtBP2 immunolabeled ribbon particles in IHCs increased with siLKB1 pretreatment. n =
4. (c, d) Pretreatment with siLKB1 recovered wave I amplitudes to baseline levels at 8
kHz (c) and attenuated the decline of wave I amplitudes at 16 kHz (d). Control: n = 10;
106 dB + siControl: n = 11; 106 dB + siLKB1: n = 6; *: 106 dB + siControl vs 106 dB +
siLKB1. Data (b, c, d) are presented as means + SD, *** p < 0.001, ** p < 0.01, * p <
0.05.
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Figure 23. Noise-induced phosphorylation of AMPKα is reduced in outer hair cells
of siLKB1 pretreatment mice. (a) Pretreatment with siLKB1 decreased p-AMPKα
immunolabeling (red) in OHCs (labeled with phalloidin staining green) of CBA/J mice 1 h
after 98-dB exposure. n = 3. (a’) Quantification of p-AMPKα immunolabeling in OHCs
displays significant decreases. n = 3. Data are presented as means + SD; ** p < 0.01.
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Discussion
Our results are in agreement with the concept that LKB1 is an AMPK kinase. This
conclusion is supported by data demonstrating that inhibition of LKB1 by siRNA reduced
98 dB noise-induced auditory thresholds to near baseline levels similar to that achieved
by pretreatment with siAMPKα1 or Compound C. Despite the excellent functional
protection, the reduction of OHC and synaptic ribbon loss by pretreatment with siLKB1
was not as great compared to that achieved by siAMPKα1 or Compound C. This implies
the involvement of other players that may be affecting noise-induced auditory thresholds
which may include the disruption of hair cell stereocilia stiffness or structure or an
alteration in the neurotransmission of SGNs, since robust p-LKB1 levels were detected
in all cell types in the cochlea. The pretreatment of siLKB1 reduced p-AMPKα by about
20%, similar to the 30% reduction detected with siAMPKα1 treatment, making a strong
case for the direct phosphorylation of AMPK by LKB1 following noise exposure.
The activation of LKB1 in the organ of Corti, including in the nuclei and cytosol of
OHCs, IHCs, supporting cells, SGNs, stria vascularis and total cochlear tissue
homogenates, after noise exposure indicates reduction of intracellular ATP levels in the
cochlea, which is in line with our previous publication (40). The discrepancy between
increased levels of p-LKB1 in Deiters cells and other supporting cell types with minimal
AMPK activation after noise exposure may be owed to an effect of intrinsic differences in
homeostatic defense systems against metabolic stress as supporting cells are resistant
to inner ear insults, while sensory hair cells are vulnerable (145-147). Alternatively, it is
plausible that off-target effects of LKB1 activity play divergent roles in cochlear sensory
cells versus supporting cells since LKB1 is known to phosphorylate a total of 14 AMPK-
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related kinases including the microtubule affinity regulating kinases (MARKs), which are
involved in cellular polarity and cytoskeleton regulation (144, 148).
The detailed molecular mechanisms by which LKB1 is activated and transported
to the cytosol remain unclear. The phosphorylation of LKB1 was localized partially within
the cytosol and nuclei of sensory and supporting cell types in the organ of Corti, SGNs
and stria vascularis (143). This high level of nuclear and cytosolic localization suggests
that serine 428 (Ser428) phosphorylation is a necessary site for LKB1 translocation. The
activation of LKB1 after noise exposure is further reinforced by the increased
colocalization of LKB1 with the pseudokinase STRADα within OHCs (142, 149-151).
In summary, we provide evidence that noise increased the phosphorylation of
LKB1 and its colocalization with the pseudokinase STRAD in sensory hair cells and
supporting cells. LKB1 mediated the loss of IHC synaptic ribbons, OHCs and auditory
function after noise exposure. Silencing of LKB1 reduced the loss of OHCs and synaptic
ribbons and decreased auditory threshold shifts. Similar to the protection by siAMPKα1,
we detected a disproportional effect of LKB1 siRNA treatment, which reduced LKB1 by
20% in OHCs specifically, and reduced the functional deficits by over 80%. This
suggests that the activity of LKB1 also likely alters multiple cellular targets, one of which
is AMPK, which may then also induce several of its own signaling pathways, causing this
amplified functional protection. Still, inhibition of AMPK (Chapter 3) was more effective in
protecting against noise-induced auditory deficits than the inhibition of LKB1, which was
not able to completely diminish AMPK phosphorylation. This suggests that the inhibition
of the LKB1 pathway is ony one mechanism to abolish AMPK activity and alternative
sources such as direct allosteric binding by AMP may contribute to NIHL.
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CHAPTER FIVE: AMPK ACTIVATION BY CAMKKβ VIA
INTRACELLULAR CALCIUM INFLUX
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Introduction
As described in Chapter 1, the disruption of calcium homeostasis by calcium
influx has been involved in NIHL. As the level of intracellular calcium increases, calciumbinding messenger protein calmodulin (CaM) acts as a calcium buffer and sensor,
binding free calcium via its two calcium-binding sites. This calcium/CaM complex
changes the conformation of CaM, allowing it to interact with a variety of proteins,
including

calcium/calmodulin-dependent

protein

kinases

(CaMKs),

a

group

of

serine/threonine protein kinases that are activated following increases in intracellular
calcium levels (152).

In particular, calcium/CaM can stimulate downstream calcium

signaling via CaMKK.
CaMKK consists of 2 isoforms, CaMKKα and CaMKKβ. CaMKKβ is primarily
expressed in the brain and neuronal tissues and plays a role in signaling neuronal
processes (153). CaMKKβ is an upstream kinase for calcium-calmodulin kinase (CaMK)
I and IV. These two kinases require the formation of calcium/CaM complexes and
phosphorylation of CaMKK to become functional. The binding of calcium/CaM exposes a
loop on CaMKI and CaMKIV that can be phosphorylated by CaMKK (154). Following its
phosphorylation, CaMKIV can translocate to the nucleus to stimulate downstream
targets, such as the transcription factor cAMPK response element-binding protein
(CREB). CaMKI primarily promotes cytosolic signaling pathways that regulate the
cytoskeleton and neuronal plasticity through the phosphorylation of mitogen-activated
protein (MAP) kinases. In addition, CaMKKβ can phosphorylate AMP-activated protein
kinase (AMPK), a cellular energy sensor that regulates the energy balance of the cell
(155) (refer to Chapter 3). The CaMKKβ-AMPK pathway requires calcium/CaM binding
in addition to phosphorylation by CaMKKβ (155) (Fig. 24).
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Calcium overload and disruption of intracellular calcium homeostasis can trigger
apoptotic or necrotic cell death through the activation of calcium dependent enzymes,
such as calcineurin, caspases, calpain proteases and endonucleases (156, 157). These
calcium-dependent enzymes can cleave cell survival proteins such as Bcl-2 or
dephosphorylate pro-apoptotic proteins such as BAD, promoting cell death (158, 159).
Moreover, CaM levels are elevated after noise trauma in the guinea pig cochlea,
increasing the activation of downstream calcium signaling pathways (85). On the other
hand, the inhibition of calcium signaling pathways prevented apoptosis in a variety of cell
types. Treatment with W7, an inhibitor of CaM, prevented apoptosis in the presence of
apoptotic bioprobes (160). Treatment with the calcium chelator, BAPTA-AM blocked
apoptosis by buffering intracellular calcium levels. Additionally, calcium influx can also
cause synaptopathy by stimulating the excessive release of glutamate neurotransmitters
at the synapse. The resulting overactivation of glutamate receptors on the post-synaptic
terminals can cause excitotoxicity and swelling of the nerve terminals, resulting

in

functional deficits.
In this chapter, the expression of CaMKKβ in the inner ear was characterized in
detail. The role of noise-induced calcium influx and subsequent CaMKKβ signaling in the
pathogenesis of NIHL and the noise-induced activation of AMPK was examined using
CaMKKβ siRNA silencing and CaMKKβ-knockout mice. In addition, we also used the
pharmacological inhibitor of calcium channels Verapamil. Verapamil is a non-selective,
L-type, high-voltage activated calcium channel blocker (161). It is a FDA-approved drug
commonly used for its antihypertensive and antianginal effects due to its potent
vasodilation activity (162). The drug plasma concentrations peak at 1-2 hours after
administration and it has a half-life of 2.8 – 7.4 h, but the half-life increases even further
after repetitive dosing. Verapamil has the ability to transverse the blood brain barrier
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(163). Generally, a low dosage is necessary to elicit protective responses in several
tissue types, including the murine cochlea (98, 164-167). Specifically, in the murine
noise model, of four L-type voltage-gated calcium channel (VGCC) blockers that
decreased the ABR threshold shift, verapamil had a significantly lower dose (98).

Figure 24. CaMKK signaling. Calcium binding protein calmodulin (dark yellow) is
activated by the binding of 4 calcium ions (green). The active complex activates
CaMKKs (red), which, when active, phosphorylate downstream kinases including CaMKI
and CaMKIV (blue). The β isoform of CaMKK also activates AMPK.
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Results
Treatment with the calcium channel blocker verapamil reduced noise-induced
hearing loss and outer hair cell death.
We first examined the contribution of calcium influx into OHCs via L-type, high voltagegated calcium channels (VGCCs) to NIHL by administering IP injections of the calcium
channel blocker verapamil and assessing the protection against NIHL. Two weeks after
98 dB SPL BBN exposure, measurement of auditory thresholds displayed a reduction of
noise-induced PTS in the verapamil-treated group compared to vehicle-treated groups at
16 and 32 kHz (Fig 25a). After 106 dB SPL, verapamil treatment reduced thresholds
shifts at 8 kHz, but was unable to alleviate NIHL at 16 and 32 kHz (Fig. 25b).
Next, OHC losses were quantified along the entire length of the cochlear
epithelium 14 days after 98 dB SPL BBN exposure. The OHC loss was decreased in the
verapamil-treated group compared to the vehicle-treated group (Fig. 25c, d). The loss of
OHCs with verapamil treatment began at 3.5 mm instead of at 3.0 mm from the apex as
detected with vehicle treatment. OHC loss was reduced from 40% to 5% at 4 mm, and
80% to 40% at 4.5 mm from the apex with verapamil treatment. In contrast, treatment of
verapamil did not alter the number of IHC synaptic ribbons at the 22 kHz region of the
sensory epithelium (3 mm from the apex) which were reduced 1 h after 106 dB noise
exposure (Fig. 26a, a’).

Noise increased CaMKKβ activity in basal outer hair cells and other cochlear cell
types.
Since CaMKKβ is a central kinase in calcium signaling cascades, the level of CaMKKβ
was examined after noise exposure at 98 dB SPL. In the unexposed animal, CaMKKβ
was weakly localized in all cell types in the organ of Corti, spiral ganglion neurons, and
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stria vascularis, but strongly expressed in the fibrocytes of the spiral ligament. One hour
after the noise exposure, CaMKKβ was increased in the organ of Corti, including in
IHCs, OHCs, pillar and Deiters cells, spiral ganglion neurons, stria vascularis, including
marginal and basal cells, and spiral ligament (Fig. 27a). Western blot of total cochlear
homogenates detected a single band for CaMKKβ at 55 kDa without alteration after
noise exposure (Fig. 27b).
We then detected CaMKKβ activity by assessing the phosphorylation of its
downstream targets, CaMKI (p-CaMKI) at threonine 177 and CaMKIV (p-CaMKIV) at
threonine 196. To quantify the intensity of p-CaMKI and p-CaMKIV staining specifically
within OHCs, surface preparations were immunolabeled. Surface preparations showed
punctate increases in the immunolabeling for p-CaMKI (Fig. 28a, a’) by 73% and pCaMKIV (Fig. 28b, b’) by 95% across basal OHCs 1 h after 98 dB exposure compared to
unexposed controls. Severe 106 dB noise exposure resulted in changes in the
immunolabeling pattern of p-CaMKI from broad punctate increases across basal OHCs
to robust increases in the cuticular plate of select basal OHCs 1 h after the exposure
(Fig. 28c). The p-CaMKI-labeled OHCs followed a gradient in which the lower basal
region (5 mm from the apex) of the epithelium displayed the majority of p-CaMKI positive
OHCs and only a few were present in the upper basal region (4 mm from the apex) (Fig.
28c’). Immunoblots of total cochlear homogenates detected a single band for p-CaMKI
and p-CaMKIV at molecular weights of 45 and 60 kDa without alteration after noise
exposure (Fig. 28d, e).
Pretreatment with CaMKKβ siRNA reduced noise-induced CaMKKβ activity and
protected against noise-induced loss of outer hair cells and hearing function.
In order to determine the contribution of CaMKKβ to NIHL, the effects of CaMKKβ siRNA
(siCaMKKβ) pretreatment on noise-induced loss of hair cells and NIHL was examined.
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Seventy-two hours after the delivery of 0.6 µg siCaMKKβ, CaMKKβ immunolabeling was
significantly reduced by 47% in basal OHCs (Fig. 29a, a’). Immunolabeling of its
downstream target p-CaMKI was not altered in unexposed cochlea, but the 98-dB noiseinduced increases in p-CaMKI were reduced by 20% with siCaMKKβ pretreatment.
Finally, pretreatment with siCaMKKβ attenuated 98-dB noise-induced threshold shifts by
35 and 30 dB at 16 and 32 kHz measured at two weeks after the exposure (Fig. 29b).
Noise-induced OHC loss was also completely prevented at 3.5 – 4 mm and reduced by
50 – 40% at 4.5 - 5.5 mm from the apex (Fig. 29c, d).

Noise induced hearing loss and outer hair cell loss were reduced in CaMKKβ-KO
mice.
Finally, CaMKKβ-knockout (CaMKKβ-KO) mice were utilized to explore the pathological
function of CaMKKβ in NIHL. We first detected an 84% decrease in CaMKKβ mRNA
copy number within the cochlea of CaMKKβ-KO mice compared to their WT
counterparts (Fig. 30e). No differences were detected for the CaMKKα isoform (Fig. 30f).
Despite these changes in CaMKKβ expression, CaMKKβ-WT, -KO and heterozygous
mice showed similar baseline auditory function (Fig. 30g)
We then assessed the effect of noise of 92, 94 and 98 dB SPL in CaMKKβ-WT, KO and –heterozygous mice. The 92 and 94 dB SPL noise exposures induced an
average of 30 dB PTS only at 32 kHz that remained unchanged between CaMKKβ-KO
and –WT littermates 2 weeks after the exposure (Fig. 30a, b). Exposures to noise at 98dB noise resulted in PTS of 30 dB at both 16 and 32 kHz. CaMKKβ-KO mice showed a
significant 10 dB reduction of PTS at 16 kHz compared to their WT littermates (Fig. 30c).
Furthermore, OHC loss was significantly decreased in the cochlea of CaMKKβ-KO mice
2 weeks after 98 dB noise exposure. Some OHC loss began at 2 mm from the apex in
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CaMKKβ-WT mice, while OHC loss was delayed to 5 mm in KO mice. There were
significant differences in OHC loss at 4.5 and 5.0 mm from the apex (Fig. 30d).

Noise-induced synaptopathy was not altered between CaMKKβ-KO and –WT mice
In order to determine if the reduced CaMKKβ activity within knockout mice can attenuate
noise-induced loss of IHC synaptic ribbons, ribbon particles were counted 1 h after 98dB noise exposure. IHCs of surface preparations from the 22 kHz region (3 mm from the
apex) of CaMKKβ-KO mice showed similar numbers of CtBP2-labeled synaptic ribbons
compared to WT mice after the exposure (Fig. 31a, b).

Noise-induced p-AMPKα is reduced in CaMKKβ-KO mice
To explore the noise-induced phosphorylation of AMPKα by CaMKKβ, CaMKKβ-KO
mice were utilized. The levels of p-AMPKα were not altered in unexposed CaMKKβ-KO
mice as detected by Western blot and immunolabeling of surface preparations. Western
blot using total cochlear homogenates showed an average of 30% reduction of pAMPKα in CaMKKβ-KO mice exposed to 98 dB noise compared to their WT littermates
(Fig. 32b). Immunolabeling for p-AMPKα in basal OHCs of surface preparations was
significantly reduced by 28% in CaMKKβ-KO mice 1 h after the exposure (Fig. 32a, a’).
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Figure 25. Verapamil treatment reduced noise-induced hearing loss and outer hair
cell loss. (a) Verapamil treatment reduces 98-dB noise-induced auditory threshold shifts
at 16 and 32 kHz. Control: n = 14, 98 dB noise: n = 12, 98 dB noise + Saline: n = 3, 98
dB noise + Verapamil: n = 10. (b) Verapamil treatment reduces 106-dB noise-induced
auditory thresholds shifts at 8 kHz. n = 6. (c) Quantitative analysis of OHCs revealed
significant protection with verapamil treatment 14 d after the exposure. 98 dB + saline: n
= 5; 98 dB + verapamil: n = 9. (c’) Representative images of OHC loss were taken from
the basal turn at 4.5 mm from the apex, scale bar = 10 µm. Data (a, b, c) are presented
as means + SD, *** p < 0.001, ** p < 0.01* p < 0.05.
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Figure 26. Verapamil treatment did not alter noise-induced inner hair cell synaptic
ribbon loss.
(a) Verapamil treatment did not alter the CtBP2 (red) immunolableled synaptic ribbons in
IHCs 1 h after 106 dB SPL BBN exposure. Representative images were taken from the
22.6 kHz region of the middle turn, n = 4, scale bar = 10 µm. Dashed circles represent
the outline of IHC nuclei.

(b) CtBP2 immunolabeled ribbon particles in IHCs were

unchanged. Data are presented as means + SD, n = 4.
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Figure 27. Noise exposure increased CaMKKβ in the organ of Corti, spiral
ganglion neurons and spiral ligament. (a) Sections display increased localization of
CaMKKβ immunolabeling (brown) in the organ of Corti, including OHCs and IHCs, pillar
cells and Deiters cells, spiral ganglion neurons, stria vascularis and spiral ligament.
Representative images were taken from the basal turn, scale bar = 10 µm, n = 3. (b)
Western blotting of total cochlear homogenates detected no change in the levels of
CaMKKβ with 98 dB noise exposures. GAPDH served as the sample loading control. n =
3.
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Figure 28. Noise exposure induced p-CaMKI and p-CaMKIV in basal outer hair
cells. (a, b) The p-CaMKI (red) (a) p-CaMKIV (red) (b) immunolabeling was stronger in
basal OHCs with phalloidin staining (green) 1 h after 98 dB SPL exposure. (a’, b’)
Quantification of p-CaMKI (a’) and p-CaMKIV (b’) immunolabeling in OHCs displayed a
significant increase after the noise exposure. (c) The basal region of the sensory
epithelium displayed a tonotopic gradient of OHCs positive for p-CaMKI (red)
immunolabeling 1 h after exposure to 106 dB SPL. (c’) Quantification of the number of pCaMKI positive OHCs along the basal turn (4-5 mm from the apex) confirmed a
significant increase. n = 4. (d, e) Western blot of total cochlear homogenates showed no
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change in the levels of p-CaMKI (d) and p-CaMKIV (e) between 98 dB noise and
controls. GAPDH served as the sample loading control. n = 3. Data are presented as
means + SD, * p < 0.05, n = 6. Representative images (a, b, c) were taken from the
basal turn, scale bar = 10 µm.
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Figure 29. Inhibition of CaMKKβ via siRNA reduced CaMKKβ activity, noiseinduced hearing loss and outer hair cell loss. (a) Treatment with siCaMKKβ
decreased CaMKKβ immunolabeling (red) in OHCs with phalloidin staining (green) in
unexposed mice 72 h after silencing. Representative images were taken from the basal
turn, scale bar = 10 µm. (a’) Quantification of CaMKKβ levels verified significant
decrease in OHCs. n = 3. (b) Pretreatment with siCaMKKβ reduced 98 dB SPL noiseinduced threshold shifts at 16 and 32 kHz 14 days after the exposure. 98 dB + siControl:
n = 11; 98 dB + siCaMKKβ: n = 7. (c) Quantitative analysis of OHCs showed significant
protection with siCaMKKβ pretreatment 14 d after the exposure. 98 dB + siControl: n =
5; 98 dB + siCaMKKβ: n = 7. (d) Representative images show DAB stained myosin VIIa
immunolabeled OHCs at 4 mm from the apex of siControl or siCaMKKβ treated cochlea.
Data (a’, b, c) are presented as means + SD, *** p < 0.001, * p < 0.05.
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Figure 30. Noise-induced hearing loss and outer hair cell loss is reduced by
CaMKKβ-knockout. (a, b) The 92 (a) and 94 (b) dB SPL noise-induced permanent
threshold shifts remained unchanged between CaMKKβ-KO and –WT mice 14 days
after the exposure. 92 dB + CaMKKβ-KO: n = 10; 92 dB + CaMKKβ-WT: n = 4; 94 dB +
CaMKKβ-KO: n = 6; 94 dB + CaMKKβ-WT: n = 7. (c) The 98 dB SPL noise-induced
threshold shifts were decreased by 10 dB at 16 kHz by CaMKKβ-KO mice 14 days after
the exposure. n = 6. (d) Quantitative analysis of OHCs showed significant protection by
CaMKKβ-KO mice at 4.5 and 5 mm from the apex 14 d after the exposure. n = 6. (e)
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CaMKKβ mRNA copy number in total cochlear tissue homogenates was reduced in
CaMKKβ-KO compared to WT mice. 18S served as loading control. n = 7. (f) CaMKKα
mRNA copy number was unchanged in total cochlear tissue homogenates of CaMKKβKO compared to WT littermates. 18S served as loading control. n = 7. (g) Baseline
auditory thresholds remain unchanged between CaMKKβ-KO, -WT, and -heterozygous
mice at 8, 16, and 32 kHz. n = 3. Data are presented as means + SD, * p < 0.05, ** p <
0.01.

99

Figure 31. Noise-attenuated inner hair cell synaptic ribbons were not altered by
CaMKKβ-knockout. (a) CaMKKβ-KO mice did not alter the CtBP2 (red) immunolableled
synaptic ribbons in IHCs at 22.6 kHz 1 h after 98 dB SPL BBN exposure. Representative
images were taken from the middle turn, n = 4, scale bar = 10µm. Dashed circles show
the outline of IHC nuclei. (b) Quantification of CtBP2 immunolabeled ribbon particles in
IHCs were unchanged. Data are presented as means + SD, n = 4.
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Figure 32. Noise-induced phosphorylation of AMPKα is reduced in outer hair cells
of CaMKKβ-knockout mice. (a) p-AMPKα (red) immunolabeling was reduced in OHCs
with phalloidin staining (green) 1 h after exposure (98 dB SPL) of CaMKKβ-KO mice
compared to wild-type littermates. n = 4. Representative images were taken from the
basal turn, Scale bar = 10 µm. (a’) Quantification of p-AMPKα immunolabeling in OHCs
confirmed a significant decrease. n = 4. (b) Immunoblot of total cochlear homogenates
shows reduction of p-AMPKα 1 h after exposure (98 dB SPL BBN) of CaMKKβ-KO mice
compared to wild-type littermates. GAPDH served as loading control. n = 3. Data (a’, b)
are presented as means + SD; ** p < 0.01, * p < 0.05.
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Discussion
Concomitant with AMPK phosphorylation, CaMKKβ activity, as indicated by the
phosphorylation of the CaMKKβ targets, CaMKI and CaMKIV, is increased by noise
exposure in basal OHCs. Interestingly, the patterning associated with p-CaMKI is altered
in a noise-intensity-dependent manner. One hour after 98 dB SPL, p-CaMKI-associated
immunofluorescence forms a punctate pattern, the intensity of which increased in OHCs
throughout the basal region of the sensory epithelium. One hour after 106 dB exposure,
the p-CaMKI-immunolabeling is robustly increased in the cuticular plate of select OHCs
in a gradient along the basal region of the sensory epithelium with the greatest number
of p-CaMKI-positive OHCs located in the lower base where OHC death is initially
observed (28). Such changes imply progressive overloading of calcium and calciumassociated signaling pathways in OHCs that are undergoing and/or very near to death
(168), as apoptotic and necrotic OHC death occurs 1 h after 106 dB SPL BBN, but not
after 98 dB noise exposure (39). Supporting cells and IHCs, which do not undergo cell
death at this time point, display no p-CaMKI immunolabeling.
This notion of noise intensity dependent changes in insults is further supported
by the protection against noise-induced auditory threshold shifts by the inhibition of
calcium channels via verapamil treatment. Verapamil treatment is able to effectively
reduce the extent of NIHL induced by 98 dB noise exposure, but does not provide any
protection from the 106 dB noise exposure, pointing to the changes in calciumassociated signaling observed in the immunohistochemistry studies. The variations in pCaMKI immunolabeling pattern may be explained by intensity-dependent changes in
calcium overloading. After the 98-dB exposure, the extent of calcium influx via
mechanotransduction (MET) channels and VGCCs is probably limited at least in part by
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calcium binding proteins including calmodulin that restrict intracellular free calcium
diffusion and incite calcium-associated signaling responses (169). After the 106-dB
exposure, the increased vibratory stimulus increases the influx of ions through both of
the channels, overwhelming calcium chelators and elevating the intracellular free
calcium level within OHCs. It is possible that calcium influx via MET channels (0.2 – 10%
of MET current) may be taken up by the mitochondria and endoplasmic reticulum of the
Hensen’s body located at the cuticular plate, which acts as a calcium store (170). The
noise-induced release of ATP into the endolymph can activate purinergic receptors
which promote inositol triphosphate (IP3) mediated calcium release at the Hensen’s body.
Furthermore, the plasma membrane calcium ATPase (PMCA), the primary mechanism
by which calcium is extruded from hair cells, is densely localized in outer hair cell
stereocilia region (171). The sum of these activities provide an explanation for the robust
increase of p-CaMKI specifically localized at the cuticular plate under this condition (61).
The possible explanation for the lack of protection of auditory thresholds and
synaptic elements by verapamil treatment at the 106-dB condition is that the
accumulation of free calcium at the synaptic ribbon active zone overwhelms our
protective strategies. Calcium influx primarily enters through VGCCs (>90%) at the
basolateral surface and functions to trigger neurotransmitter release at the ribbon
synapse. Thus, after the 106-dB exposure, the influx of calcium through VGCCs can
lead to a surge of neurotransmitter release, resulting in excitotoxicity of the synapse.
This introduces a two-hit pathological effect of calcium-associated pathologies at both
the apical and basal poles of hair cells, which may overwhelm protective responses
elicited by verapamil treatment.
CaMKKβ appears to mediate AMPK’s contribution to the progression of NIHL.
Inhibition of CaMKKβ by siRNA reduces 98 dB noise-induced auditory thresholds,
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although the protection is not as great as that of siAMPKα1, Compound C, or siLKB1.
Considering the robust reduction of CaMKKβ mRNA and p-AMPKα protein in the
knockout mice, the 10 dB degree of protection against auditory threshold shifts and
OHCs after noise exposure seems inadequate compared to the 30 dB protection elicited
by CaMKKβ siRNA. Since the activation of AMPK is noise intensity-dependent, the
relatively lower permanent threshold shift induced by the 98 dB exposure in the CaMKKβ
knockout of C57B6/J mice may be a plausible explanation. Furthermore, studies have
shown that the two strains differ in noise-induced cochlear pathology. The CBA/J strains
show significant reductions in the endocochlear potential, abnormal stria vascularis and
spiral ligament pathology acutely after noise trauma compared to the C57B6/J strains
(172). In addition, mRNA levels of CaMKKα are not altered in the knockout mice.
Although the activity of CaMKKα from isolated rat brain is 7-fold lower than that of
CaMKKβ in phosphorylating AMPK (173), it does not exclude the possibility that
CaMKKα activity is able to phosphorylate AMPK more efficiently in the absence of
CaMKKβ, therefore, masking the effect of CaMKKβ-KO.
Despite the partial protection of auditory thresholds observed with verapamil
treatment and by CaMKKβ-KO mice, these therapies were unable to protect against the
loss of synaptic ribbons. This contrasts with the evidence in Chapters 3 and 4 showing
protection of noise-induced synaptic ribbon loss when either LKB1 or AMPK are
targeted. It is likely that our protective strategies were overwhelmed by calcium influx
within hair cells. This is especially likely in the case of synaptopathy, since calcium
stimulates the excessive release of the neurotransmitter glutamate, which causes
excitotoxicity. The activation of only a few VGCCs at the synaptic active zone is
sufficient in eliciting both functional and pathological effects. In fact, a previous study has
estimated that less than ten Cav1.3 VGCCs are open at a time to induce a high calcium
104

concentration nanodomain near the synaptic ribbon active zone compared to the 80
channels localized per active zone (174). It is likely that verapamil treatment was unable
to completely eliminate calcium influx through all 80 channels and thus, we were unable
to protect against the overloading of calcium. Still, we cannot exclude the possibility that
a sub-optimal verapamil dose was utilized. Furthermore, since synaptopathy is primarily
caused by increased calcium levels at the synaptic ribbon, rather than calcium signaling
through CaMKKs, it is reasonable that a lack of protection was exhibited by the
CaMKKβ-KO mice.
Finally, the discrepancy in CaMKKβ, p-CaMKI and p-CaMKIV levels between
immunolabeled OHCs or paraffin sections and immunoblots is possibly due to the fact
that the cochlear tissue homogenates includes multiple cell types, including a variety of
supporting cells, spiral ganglion neurons, and strial fibrocytes, masking changes
occurring only in OHCs. In summary, our results demonstrate changes in calcium
signaling in a noise intensity-dependent manner. Additionally, we demonstrate that
inhibition of CaMKKβ either via silencing or knockout mice reduce the phosphorylation of
AMPKα and the extent of OHC loss and NIHL. These results suggest that calcium influx
after noise exposure is another source in addition to intracellular ATP reduction which
contributes to NIHL.
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CHAPTER SIX: SUMMARY AND FUTURE DIRECTIONS
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SUMMARY AND FUTURE DIRECTIONS
In summary, these results present for the first time that noise-intensity dependent
phosphorylation of AMPKα in sensory hair cells facilitates NIHL by mediating loss of IHC
synaptic ribbons and OHCs. This noise-induced activation of AMPKα1 is facilitated by
two pathways which converge upon AMPKα1: one initiated by changes in the
intracellular ATP levels of the cell and activated by LKB1, and the other by CaMKKβ,
triggered by increases in intracellular calcium. Agents that inhibit either of these
pathways reduce the extent of AMPK phosphorylation and, subsequently, NIHL and
OHC or synaptic ribbon loss (Fig. 33).

Figure 33. Summary. Noise trauma, which induces permanent threshold shifts and
outer hair cell loss, increases the phosphorylation of AMPKα, hair cell loss and
subsequently hearing loss in a noise intensity-dependent fashion. Reduction of AMPKα
by AMPK inhibitors, Compound C or AMPKα1 siRNA, decreases p-AMPKα and protects
from noise-induced losses of OHC and synaptic ribbons and hearing loss.
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Concomitantly, noise trauma induces the phosphorylation of LKB1 and the CaMKKβ
targets, p-CaMKI and p-CaMKIV. Inhibition of CaMKKβ by siRNA and knockout
decreases the level of CaMKKβ, alleviating NIHL. Reduction of LKB1 by siRNA reduces
the level of p-LKB1 and, subsequently, promotes the protection of noise-induced hair cell
loss and NIHL. Finally, either inhibition of LKB1 via siRNA or knockout of CaMKKβ
diminishes the expression of p-AMPKα, suggesting noise-induced activation of AMPK is
mediated through both intracellular ATP reduction and calcium influx.
This conclusion is supported by evidence demonstrating that the inhibition of
AMPK activity with the selective AMPK inhibitor Compound C or through pretreatment
with siAMPKα1 reduces p-AMPKα and NIHL via protection from losses of IHC synaptic
ribbons and OHCs. Concomitant with the phosphorylation of AMPK, the activities of
LKB1 (p-LKB1) and CaMKKβ (p-CaMKI/IV), significantly increases after noise exposure.
Inhibition of LKB1 by siRNA and CaMKKβ via siRNA or genetic knockout reduces pAMPKα and the extent of NIHL, suggesting that the activation of AMPK via LKB1 and
CaMKKβ following noise exposure contributes to the pathogenesis of NIHL. Moreover,
the efficiency of systemic pharmacological treatment with compound C implicates a
novel therapeutic target in prevention and amelioration of NIHL.
The expression of total levels of AMPKα1, AMPKα2, LKB1 and CaMKKβ
significantly increases within sensory cells and supporting cells of the organ of Corti,
SGNs and the spiral ligament at an acute time point 1 h after 98-dB noise exposure. This
acute and rapid change in gene expression suggests that these key homeostasis
molecules may be primary or secondary response genes that are activated rapidly in
response to noise insults. Immediate early genes or primary response genes are genes
that are induced following an extracellular signal in a rapid manner (within 30 min) that
does not require an initial round of protein synthesis. On the other hand, secondary
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response genes are activated at later times (2 h) in response to the initial primary
response genes, which typically encode transcription factors such as c-fos, c-jun, and
AP-1, which increase in the organ of Corti and lateral wall tissues of the noise-exposed
guinea pig cochlea (175).
The current study implies that noise-induced pathological signaling events may
vary with intensity of the noise exposure. Protection of auditory threshold shifts and
OHCs by inhibiting AMPK (siAMPKα1, Compound C and AMPKα1-KO) and calciumCaMKKβ (verapamil) is significantly less effective for the more severe 106 dB noise
condition compared to the 98 dB noise conditions. This discrepancy was most obvious
with verapamil treatment, which does not provide protection from 106 dB noise-induced
auditory threshold shifts, while inhibition of AMPK reduces protection. However, one
cannot rule out that this may be an effect of a less-than-optimal concentration or drug
treatment to target VGCCs. The noise-intensity dependent changes in signaling
pathways is also emphasized by the alteration of the immunolabeling pattern of pCaMKI, between 98 and 106 dB noise conditions. As discussed in Chapter 5, the
localization of p-CaMKI from the cytosol to the cuticular plate is suggestive of an IP3mediated calcium release at the Hensen’s body and implicate an initial protective
response (mitochondrial and ER calcium uptake) or calcium extrusion via PMCA pumps,
followed by a pathological reaction (calcium release). This evidence alludes to the
ineffectiveness of protective cellular responses under increasing noise severities.
Several hypotheses may explain these findings: 1) Severe noise exposure at
106 dB might induce multiple cell death events in addition to the activation of AMPK,
such as receptor-interacting protein kinases (39) which may bypass calcium or ATPinitiated pathways, 2) Since inhibition of LKB1 or AMPK was able to provide greater
protection than the blockade of calcium influx against 106 dB noise exposure, energy
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homeostasis may contribute initially to noise-induced cochlear pathology, and the
dysregulation of calcium homeostasis may be a secondary effect of ATP depletion, 3)
Excessive overloading of calcium and calcium-associated cell death signaling pathways
are more quickly activated under the 106 dB noise condition, accelerating cell death
pathways and, thus, making therapies less effective in preventing or protecting against
death. The third hypothesis is supported by evidence in Chapter 5 showing a lack of
protection against noise-induced synaptopathy by inhibition of calcium influx through
VGCCs via verapamil or inhibition of CaMKKβ via knockout mice.
Overall, this study identifies AMPKα as a novel therapeutic target to prevent
NIHL. Current studies have yet to establish a comprehensive target for NIHL and have
only addressed therapies that play partial roles in protection. Because it is likely that
NIHL is an effect of multiple pathological processes, a key goal is to identify an inclusive
therapy. AMPK provides a prospective target that addresses many intertwining pathways
from multiple pathological stimuli and thus delivers a promising approach. As described
in detail in Chapter 1, several phenomena including calcium influx, ATP depletion and
generation of ROS likely plays a role in initiating and exacerbating the pathological
responses of sensory cells that lead to NIHL. AMPK sits at a crossroads between these
3 events and thus may more effectively address the complexities of NIHL signaling
pathways as a therapeutic target. However, further investigations are necessary to
advance the current study and to address the unanswered questions. Of particular
importance is the need to assess differences in the signaling pathways between sensory
hair cells, which are injured by noise exposure, and supporting cells that are resistant to
noise insults.
As demonstrated in Chapter 3 – 5, noise-induced changes in sensory hair cells,
such as increases in expression of total AMPKα1, AMPKα2, p-LKB1 and CaMKKβ were
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also present in supporting cell types, despite the inconsistency in noise-induced cell fate.
Addressing the fundamental differences in downstream signaling pathways associated
with the activation of these molecules is necessary in order to determine key therapeutic
targets, while limiting off-target effects. It is possible that the maintenance of
homeostasis and ion imbalances is more effective and efficient due to the present of gap
junctions between supporting cell types that allow for diffusion and flux of ions and
second messengers. The buffering of calcium and potassium ions among supporting
cells have been reported. Supporting cells take up potassium ions from the perilymph
fluid surrounding the basolateral pole of hair cells. These potassium ions are recycled
back to the endolymph through a series of gap junctions between supporting cells,
fibrocytes and the cells of the stria vascularis. Dysfunction of these gap junctions can
reduce the endocochlear potential and alter auditory function (176, 177). Additionally,
intercellular calcium waves have been detected among Deiter’s cells in response to
damage and extracellular ATP signals, and these calcium waves are propagated
through connexin gap junction channels (62, 178, 179). The cell-cell communication of
supporting cells provide increased buffering capacity compared to the sensory hair cells
and may significantly contribute to an altered cellular response to the activities of AMPK,
LKB1 and CaMKKβ. The increased aptitude of supporting cells to recover from a
metabolic disruption may prevent a chronic activation of these signaling molecules that
could cause the upregulation of pro-apoptotic genes, such as Bim, the activities of proapoptotic kinases such as JNK and may increase ROS and RNS through increased nitric
oxide synthase activity. Alternatively, AMPK activity may more quickly resolve cellular
imbalances in supporting cells by upregulating mitochondrial biogenesis genes such as
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) or
stimulating autophagy.
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Moreover, changes in noise-induced signaling pathways are also apparent in the
stria vascularis, spiral ligament, and SGNs. Chapter 3 and 4, highlight the potential
involvement of the stria vascularis in the regulation of noise-induced energy
homeostasis. The Na+-K+-ATPase within marginal cells of the stria vascularis transports
potassium ions inward from the intrastrial space in order to maintain the low sodium,
high potassium content of the endolymph. After noise insults, it is probable that
potassium recycling is increased in order to sustain the endocochlear potential and
maintain appropriate ionic balances, necessitating an increased demand for ATP
production to drive these energy-consuming processes. Additionally, the release of ATP
by marginal cells occurs after noise exposure. Extracellular ATP within the endolymph
fluid can act upon purinergic receptors on the plasma membrane of marginal cells to
stimulate inositol triphosphate (IP3)-mediated calcium release. This effect may in turn
increase ATP expenditure through the activity of calcium-ATPases, which serve to
remove the intracellular calcium from the cytosol into the ER. Altogether, these various
mechanisms of energy expenditure may result in energy failure and ionic imbalances of
these cell types and of the endolymph. The reduction of ATP levels probably upregulates
the expression of p-LKB1 and AMPK as a protective response, while CaMKKβ
expression may also increase in response to the secondary intracellular calcium release
in the stria vascularis. Our results showing increases in expression of AMPKα1/2, pLKB1 and CaMKKβ support this hypothesis. Thus, reductions in auditory function as
assessed by auditory thresholds without changes in hair cell death may be a result of
underlying pathologies in the ionic imbalances specific to the stria vascularis.
The pharmacological agents, Compound C and Verapamil, protect against noiseinduced damage of hearing function and hair cells, particularly in the case of Compound
C. Despite the efficiency of this systemic treatment, advanced investigations are
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necessary in order to examine the effectiveness of these pharmacological treatments. In
this study, both pharmacological agents are delivered systemically to mimic a clinically
paradigm of an oral medication. However, because both drugs are delivered at time
points before and after the noise exposure, it is not clear whether the effects were a
result of a protection effect, a rescue effect, or a combination of both. Further
investigations are necessary to distinguish the functional effects of pharmacological
treatments at time point only prior to noise exposure and only after noise exposure.
These studies would provide information on the most effective drug delivery system for a
clinical application. Additionally, we would better understand the protection from a
mechanistic standpoint by determining key timing of pathological responses.
The use of knockout mice models in the study reveale a complex relationship
between the activation of AMPK signaling and its outcome, whether protective or
pathological. Inhibition of AMPK via siRNA (siAMPKα1) or the use of a pharmacological
inhibitor (Compound C) was able to reduce the extent of noise-induced cochlear deficits,
contrasting with the worsening of cochlear deficits detected in AMPKα1-KO mice. This
highlights the need to address the differences between a reduction in the activity of
AMPK versus the knockout of the gene and its function. The inconsistencies may point
to differences in the degree and timing of gene inhibition. In this study, siRNA silencing
partially reduces AMPKα1 expression by 20% in OHCs and subsequently reduces its
activity by 30% as determined by AMPKα phosphorylation. This partial reduction still
allows for 70% activity of AMPK within OHCs to maintain the necessary AMPK cellular
functions. The partial 30% reduction of its activity may be sufficient to reduce the
pathological response AMPK may have on the cell at least to some extent. This
contrasts with the knockout study which eliminates the AMPK gene, including its
potentially protective function. Furthermore, the siRNA silencing acutely and transiently
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inhibited AMPK activity. This acute expression prevents any overcompensation that the
cell may adapt to in the knockout mouse.
In order to more clearly understand the pathological or pro-survival function of
AMPK in the noise-exposed cochlea, further studies are necessary to examine the
duration of AMPK activation to identify the key timing or circumstance in which AMPK
activation converts from a protective to pathological function. We suspect that its role
depends on noise intensity, where exposures to noise levels that cause temporary
hearing losses may promote cell preservation through the energy conserving activity of
AMPK’s downstream targets, such as autophagy (71). On the other hand, exposure to
noise that causes permanent hearing losses may lead to a sustained activation of AMPK
as part of the cell’s protective response to the increased level of stress. Under this
condition, the chronic activation of AMPK may alter cellular events, which may include
the upregulation of pro-apoptotic genes as the cell prepares to eliminate the damaged
cell. If this hypothesis is true, treatment with an AMPK activator, such as metformin,
under temporary hearing loss noise conditions may worsen recovery from NIHL.
Determining a balance for AMPK activation and inhibition may be a key strategy for
designing future therapies.
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